data_1dcj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dcj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.4 m-30 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 6' ' ' SER . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.56 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.2 m-70 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.523 ' N ' HD11 ' A' ' 39' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.536 HD23 ' CG2' ' A' ' 26' ' ' VAL . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 HD23 ' CB ' ' A' ' 72' ' ' PRO . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 55' ' ' PHE . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.527 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.577 HG13 ' CE2' ' A' ' 55' ' ' PHE . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' OE1' ' OD2' ' A' ' 9' ' ' ASP . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' CD1' HG21 ' A' ' 26' ' ' VAL . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.544 HG21 ' CG ' ' A' ' 22' ' ' PRO . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.677 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.603 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.603 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.586 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.633 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.555 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.633 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' HG22 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.4 m-70 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 13' ' ' ASP . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' HD13 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 72' ' ' PRO . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 55' ' ' PHE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.539 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 41' ' ' ILE . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.585 ' CG1' ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.55 HG22 ' CD2' ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.539 HG22 ' CG ' ' A' ' 22' ' ' PRO . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.683 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.637 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.593 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.593 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.683 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 14.7 m-70 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.52 ' N ' HD11 ' A' ' 39' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 13' ' ' ASP . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' N ' HD13 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD23 ' CG2' ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.617 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG13 ' CB ' ' A' ' 55' ' ' PHE . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.526 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 55' ' ' PHE . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.538 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD2' ' A' ' 5' ' ' PHE . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 26' ' ' VAL . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.626 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.592 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.583 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.503 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.63 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.726 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' N ' HG22 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 ' N ' HD13 ' A' ' 39' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' HD13 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.564 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 HG11 ' CD2' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.501 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 55' ' ' PHE . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.594 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' CB ' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.472 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 22' ' ' PRO . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.675 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.594 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.605 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.58 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.607 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.632 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.58 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.428 HG21 ' C ' ' A' ' 67' ' ' GLU . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.535 ' N ' HG21 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.557 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.6 m-70 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.52 ' N ' HD12 ' A' ' 39' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 13' ' ' ASP . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.571 ' N ' HD11 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.534 ' CB ' HD12 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 55' ' ' PHE . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.552 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 61' ' ' HIS . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.52 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 39' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.554 ' CG2' HD22 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 22' ' ' PRO . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.688 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.639 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.588 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.626 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.506 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.688 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' HG21 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.71 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.6 m-70 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.498 ' N ' HD12 ' A' ' 39' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' N ' HD13 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 43' ' ' ALA . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.541 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.577 HG12 ' CG ' ' A' ' 55' ' ' PHE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.519 ' CB ' HD11 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG13 ' CE2' ' A' ' 55' ' ' PHE . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 61' ' ' HIS . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 29' ' ' THR . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.562 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.543 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.545 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.676 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 23' ' ' VAL . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.608 ' CE2' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.603 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.603 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.585 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.606 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.608 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.71 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.632 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 14.8 m-70 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.528 ' N ' HD12 ' A' ' 39' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD22 ' CB ' ' A' ' 72' ' ' PRO . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG11 ' CG ' ' A' ' 55' ' ' PHE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.536 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 55' ' ' PHE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.531 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.531 ' CG2' ' HG3' ' A' ' 22' ' ' PRO . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.678 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.527 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.595 ' CB ' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' CB ' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.589 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.624 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.589 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.571 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.708 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.631 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.554 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.2 m-70 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.518 ' N ' HD12 ' A' ' 39' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 ' N ' ' A' ' 13' ' ' ASP . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.549 ' N ' HD11 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 43' ' ' ALA . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.549 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.541 ' CB ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 55' ' ' PHE . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 61' ' ' HIS . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.538 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CD1' HG22 ' A' ' 26' ' ' VAL . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.554 HG21 ' CG ' ' A' ' 22' ' ' PRO . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.688 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.613 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.572 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.572 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' C ' ' A' ' 67' ' ' GLU . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.599 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.688 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.639 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 13.7 m-70 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 39' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 13' ' ' ASP . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.547 ' N ' HD11 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 HD23 ' CB ' ' A' ' 72' ' ' PRO . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.562 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.542 ' CB ' HD12 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 55' ' ' PHE . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.607 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.538 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.577 HG22 ' CD2' ' A' ' 61' ' ' HIS . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 5' ' ' PHE . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.544 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.686 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.573 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.578 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.639 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.686 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.632 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.626 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 18.8 m-70 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' HD13 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 55' ' ' PHE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.52 ' CB ' HD11 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.589 HG12 ' CE2' ' A' ' 55' ' ' PHE . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.538 ' HE1' ' CB ' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.562 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.55 ' CG2' HD21 ' A' ' 15' ' ' LEU . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.543 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 22' ' ' PRO . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.678 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.595 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.586 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.525 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.651 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.651 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.643 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' N ' HG21 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.031 0.443 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.0 m-70 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.516 ' N ' HD12 ' A' ' 39' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 13' ' ' ASP . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' N ' HD13 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 55' ' ' PHE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.528 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 55' ' ' PHE . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.616 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.541 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.563 ' CG2' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.57 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.55 ' N ' HD22 ' A' ' 15' ' ' LEU . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 22' ' ' PRO . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.682 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.616 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 30' ' ' VAL . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' CD1' ' HG3' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.61 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.606 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.682 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.623 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.632 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.528 ' N ' HG22 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.099 0.476 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.8 m-70 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.498 ' N ' HD12 ' A' ' 39' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD22 ' CB ' ' A' ' 72' ' ' PRO . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.625 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.531 ' CB ' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 55' ' ' PHE . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.533 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.545 ' CG2' ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.555 HG22 ' CG ' ' A' ' 22' ' ' PRO . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.683 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.539 ' CD1' ' HG3' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.612 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.571 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.683 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.646 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.722 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.545 ' HG2' ' CG2' ' A' ' 38' ' ' THR . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.5 m-30 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 6' ' ' SER . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 39' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' CD2' ' CG2' ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.548 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 ' CD2' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.532 ' CB ' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 55' ' ' PHE . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 61' ' ' HIS . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.533 HD13 ' CG2' ' A' ' 26' ' ' VAL . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.54 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.68 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.605 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.622 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.582 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.648 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.587 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.68 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.625 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.696 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.643 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.711 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.076 0.465 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.4 m-70 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' HD11 ' A' ' 39' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.557 HD11 ' N ' ' A' ' 13' ' ' ASP . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.557 ' N ' HD11 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG13 ' CD2' ' A' ' 55' ' ' PHE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.552 ' CB ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.588 HG13 ' CE2' ' A' ' 55' ' ' PHE . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 5' ' ' PHE . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.56 ' CG2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' N ' HD22 ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 HG22 ' CG ' ' A' ' 22' ' ' PRO . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.687 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.583 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.631 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.589 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.585 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.605 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.617 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.617 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.63 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.47 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 44.3 m-70 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.497 ' N ' HD13 ' A' ' 39' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' HD13 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.57 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 43' ' ' ALA . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' MET . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' O ' ' CD ' ' A' ' 27' ' ' ARG . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.511 ' CB ' HD11 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 55' ' ' PHE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.551 ' HA ' ' ND2' ' A' ' 32' ' ' ASN . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 61' ' ' HIS . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.505 HD11 ' CD2' ' A' ' 5' ' ' PHE . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.556 ' CG2' HD22 ' A' ' 15' ' ' LEU . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' CG ' ' A' ' 22' ' ' PRO . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.691 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.607 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.607 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.615 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.525 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.629 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.629 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.621 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' N ' HG22 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.721 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.09 0.471 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.1 m-70 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 ' N ' HD13 ' A' ' 39' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 55' ' ' PHE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.519 ' CB ' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 55' ' ' PHE . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.597 HG22 ' CD2' ' A' ' 61' ' ' HIS . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.534 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 22' ' ' PRO . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.676 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.581 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.607 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.638 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.552 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.634 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.637 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.721 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.634 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HB3' ' CG2' ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.6 m-30 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.54 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 14.0 m-70 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 13' ' ' ASP . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.625 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 55' ' ' PHE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.525 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' CE2' ' A' ' 55' ' ' PHE . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.651 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.521 ' HE2' ' CB ' ' A' ' 79' ' ' LYS . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 5' ' ' PHE . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' CG2' ' A' ' 26' ' ' VAL . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.472 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.545 HG21 ' CG ' ' A' ' 22' ' ' PRO . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.69 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.651 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.607 ' HB ' ' CD2' ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.552 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB2' HD21 ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.69 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.62 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' CB ' ' HE2' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.078 0.466 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 17.5 m-70 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' ASP . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD2' HG23 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.456 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 55' ' ' PHE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG13 ' CE2' ' A' ' 55' ' ' PHE . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 61' ' ' HIS . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.514 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 5' ' ' PHE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.542 HG23 ' CD2' ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.542 HG21 ' CB ' ' A' ' 22' ' ' PRO . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.675 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' HG23 ' A' ' 23' ' ' VAL . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.592 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.582 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 67' ' ' GLU . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.512 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.634 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.617 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.537 ' HB3' ' CG2' ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.008 0.432 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 6' ' ' SER . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 16.8 m-70 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.532 ' N ' HD11 ' A' ' 39' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.543 ' N ' HD13 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD22 ' CB ' ' A' ' 72' ' ' PRO . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.626 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG13 ' CD2' ' A' ' 55' ' ' PHE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.536 ' CB ' HD11 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 55' ' ' PHE . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.638 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.569 ' HA ' ' ND2' ' A' ' 32' ' ' ASN . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 27' ' ' ARG . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 29' ' ' THR . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.556 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.533 HG23 ' CG ' ' A' ' 22' ' ' PRO . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.667 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.638 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.589 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.589 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.561 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.667 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.635 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.536 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.72 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.4 m-30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.063 0.459 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 15.0 m-70 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.514 ' N ' HD12 ' A' ' 39' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' CG2' ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD23 ' CB ' ' A' ' 72' ' ' PRO . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 55' ' ' PHE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.545 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 55' ' ' PHE . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.634 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 26' ' ' VAL . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 22' ' ' PRO . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.662 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.634 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.608 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.634 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.588 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.627 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.662 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.72 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.628 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HD3' ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.87 156.95 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.35 109.39 16.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.7 mt -96.74 -5.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.4 m-30 -86.9 16.52 4.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.717 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 6' ' ' SER . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.56 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.2 m-70 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.523 ' N ' HD11 ' A' ' 39' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.536 HD23 ' CG2' ' A' ' 26' ' ' VAL . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 HD23 ' CB ' ' A' ' 72' ' ' PRO . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.52 HG11 ' CD2' ' A' ' 55' ' ' PHE . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.527 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.577 HG13 ' CE2' ' A' ' 55' ' ' PHE . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.579 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' OE1' ' OD2' ' A' ' 9' ' ' ASP . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' CD1' HG21 ' A' ' 26' ' ' VAL . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.544 HG21 ' CG ' ' A' ' 22' ' ' PRO . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.677 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.563 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.603 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.603 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.586 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.633 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.555 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.633 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' HG22 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm -58.8 132.61 54.42 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -178.05 -172.48 42.53 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.3 p -106.47 120.47 42.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -65.84 133.15 50.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' HB3' HG12 ' A' ' 64' ' ' VAL . 30.6 mt -78.43 -17.58 56.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -86.77 16.22 5.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.912 . . . . 0.0 109.73 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.4 m-70 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 13' ' ' ASP . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' HD13 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 72' ' ' PRO . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 55' ' ' PHE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.539 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 41' ' ' ILE . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.585 ' CG1' ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.55 HG22 ' CD2' ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.539 HG22 ' CG ' ' A' ' 22' ' ' PRO . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.683 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.637 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.593 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.593 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.683 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -64.61 106.66 1.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.45 168.37 28.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.538 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -103.55 114.7 29.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' O ' ' OG ' ' A' ' 6' ' ' SER . 0.3 OUTLIER -77.57 132.96 38.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.5 mt -67.6 -24.99 65.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 -86.64 16.05 5.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 14.7 m-70 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.52 ' N ' HD11 ' A' ' 39' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 13' ' ' ASP . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' N ' HD13 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD23 ' CG2' ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG13 ' CB ' ' A' ' 55' ' ' PHE . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.526 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 55' ' ' PHE . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.538 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD2' ' A' ' 5' ' ' PHE . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 26' ' ' VAL . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.626 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.592 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.583 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.503 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.63 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.726 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' N ' HG22 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 1.0 OUTLIER -53.73 142.06 24.64 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.99 -172.74 38.2 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.982 -1.454 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mtt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.0 m -110.14 121.7 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -96.83 128.59 43.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 mt -80.33 -28.77 38.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -85.88 15.38 4.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -0.923 . . . . 0.0 109.686 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 ' N ' HD13 ' A' ' 39' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' HD13 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.564 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 HG11 ' CD2' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.501 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 55' ' ' PHE . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.594 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' CB ' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.472 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 22' ' ' PRO . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.675 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.594 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.605 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.58 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.607 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.632 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.58 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.428 HG21 ' C ' ' A' ' 67' ' ' GLU . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.638 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.535 ' N ' HG21 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt -58.51 135.11 57.22 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.08 -172.6 41.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 t -61.53 108.06 0.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.97 135.86 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.528 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 65' ' ' ALA . 30.3 mt -72.93 -2.89 22.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 -86.98 16.59 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.576 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.557 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.6 m-70 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.52 ' N ' HD12 ' A' ' 39' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 13' ' ' ASP . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.571 ' N ' HD11 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.534 ' CB ' HD12 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 55' ' ' PHE . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.552 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 61' ' ' HIS . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.52 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 39' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' CG2' HD22 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 22' ' ' PRO . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.688 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.639 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.588 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.626 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.506 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.688 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' HG21 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER -58.03 138.71 55.73 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -177.95 -172.53 42.5 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.65 138.22 35.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 100.5 8.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 5.4 mt -69.72 -6.26 30.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.71 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -85.54 17.48 3.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -0.822 . . . . 0.0 109.893 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.6 m-70 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.498 ' N ' HD12 ' A' ' 39' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' N ' HD13 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 43' ' ' ALA . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.541 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.577 HG12 ' CG ' ' A' ' 55' ' ' PHE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.519 ' CB ' HD11 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG13 ' CE2' ' A' ' 55' ' ' PHE . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 61' ' ' HIS . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 29' ' ' THR . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.437 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.562 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.543 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.545 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.676 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 23' ' ' VAL . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.608 ' CE2' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.603 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.603 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.606 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.608 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.71 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.632 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.95 129.54 42.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -147.44 -172.23 17.37 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.12 105.67 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -113.41 118.04 33.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 65' ' ' ALA . 27.2 mt -68.98 -9.33 51.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -86.45 16.79 4.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.852 . . . . 0.0 109.835 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 14.8 m-70 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.528 ' N ' HD12 ' A' ' 39' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD22 ' CB ' ' A' ' 72' ' ' PRO . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG11 ' CG ' ' A' ' 55' ' ' PHE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.536 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 55' ' ' PHE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.531 ' CG2' ' HG3' ' A' ' 22' ' ' PRO . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.678 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.527 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.595 ' CB ' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' CB ' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.589 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.624 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.589 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.571 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.708 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.631 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' N ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? -59.73 135.54 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.76 -172.59 36.47 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.339 0.59 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -106.61 126.02 51.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.471 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' O ' ' OG ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -101.67 105.88 16.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.541 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.07 -24.62 60.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 -87.04 16.04 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.603 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.554 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.2 m-70 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.518 ' N ' HD12 ' A' ' 39' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD11 ' N ' ' A' ' 13' ' ' ASP . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' N ' HD11 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 43' ' ' ALA . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.549 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.541 ' CB ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 55' ' ' PHE . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.547 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 61' ' ' HIS . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.538 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CD1' HG22 ' A' ' 26' ' ' VAL . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.554 HG21 ' CG ' ' A' ' 22' ' ' PRO . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.688 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.613 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.572 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.572 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' C ' ' A' ' 67' ' ' GLU . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.599 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.688 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.639 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 0.8 OUTLIER -59.67 106.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.5 166.9 26.34 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.586 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.7 p -94.9 160.4 14.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -109.74 97.55 7.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 4.5 mt -80.34 -25.79 39.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.3 m-30 -86.65 16.28 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.609 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 13.7 m-70 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 39' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 13' ' ' ASP . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' N ' HD11 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD23 ' CB ' ' A' ' 72' ' ' PRO . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.562 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.542 ' CB ' HD12 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 55' ' ' PHE . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.538 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.577 HG22 ' CD2' ' A' ' 61' ' ' HIS . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 5' ' ' PHE . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.544 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.686 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.578 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.639 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.686 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.632 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.626 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? -59.69 133.48 56.13 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.515 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . 179.91 -172.27 43.84 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.534 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.6 m -77.21 123.63 26.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.38 137.61 42.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 64' ' ' VAL . 24.1 mt -83.31 -8.1 59.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.481 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.716 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 -86.24 16.25 4.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 18.8 m-70 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' HD13 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 HD21 ' CG2' ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 55' ' ' PHE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.52 ' CB ' HD11 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.589 HG12 ' CE2' ' A' ' 55' ' ' PHE . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.538 ' HE1' ' CB ' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.562 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.55 ' CG2' HD21 ' A' ' 15' ' ' LEU . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.543 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.566 HG22 ' CB ' ' A' ' 22' ' ' PRO . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.678 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.595 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.586 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.525 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.651 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.643 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' N ' HG21 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -69.73 110.82 5.11 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.31 160.11 13.09 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.547 179.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 t -55.26 160.68 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.428 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.09 118.79 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 65' ' ' ALA . 50.3 mt -89.75 -0.99 57.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -85.32 16.51 3.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.875 . . . . 0.0 109.914 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.0 m-70 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.516 ' N ' HD12 ' A' ' 39' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 13' ' ' ASP . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' N ' HD13 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 55' ' ' PHE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CB ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 55' ' ' PHE . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.616 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.541 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 61' ' ' HIS . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 26' ' ' VAL . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.563 ' CG2' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.57 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.55 ' N ' HD22 ' A' ' 15' ' ' LEU . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 22' ' ' PRO . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.682 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.616 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.581 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 30' ' ' VAL . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.543 ' CD1' ' HG3' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.61 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.606 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.682 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.623 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.632 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' N ' HG22 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? -57.61 132.49 53.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.517 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -138.6 -172.32 12.51 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' CA ' ' CD ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -61.89 159.43 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.69 154.97 36.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.512 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 mt -98.71 -40.41 8.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -86.51 16.01 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.162 -0.961 . . . . 0.0 109.751 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.8 m-70 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.498 ' N ' HD12 ' A' ' 39' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD22 ' CB ' ' A' ' 72' ' ' PRO . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.625 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.531 ' CB ' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 55' ' ' PHE . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.533 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.545 ' CG2' ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.555 HG22 ' CG ' ' A' ' 22' ' ' PRO . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.683 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' CD1' ' HG3' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.612 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.571 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.683 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.646 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.722 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.545 ' HG2' ' CG2' ' A' ' 38' ' ' THR . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm -56.62 129.57 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.01 -172.62 36.68 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.294 0.568 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.33 160.47 15.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.69 97.23 11.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.513 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.448 ' HB3' HG12 ' A' ' 64' ' ' VAL . 22.1 mt -98.86 -11.75 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.696 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.5 m-30 -86.53 16.1 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.392 -0.818 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 6' ' ' SER . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 39' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' CD2' ' CG2' ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.548 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 ' CD2' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.532 ' CB ' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 55' ' ' PHE . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.547 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 61' ' ' HIS . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.533 HD13 ' CG2' ' A' ' 26' ' ' VAL . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.54 HG22 ' CG ' ' A' ' 22' ' ' PRO . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.68 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.605 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.622 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.582 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.648 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.587 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.68 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.625 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.696 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.643 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.65 106.19 0.93 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.27 167.68 27.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.445 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -52.75 160.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.58 107.34 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.663 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.2 mt -93.31 -9.29 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.711 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -85.83 16.37 4.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.762 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 12.4 m-70 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' HD11 ' A' ' 39' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.557 HD11 ' N ' ' A' ' 13' ' ' ASP . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.557 ' N ' HD11 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 ' CG2' ' A' ' 42' ' ' ILE . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG13 ' CD2' ' A' ' 55' ' ' PHE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.552 ' CB ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.588 HG13 ' CE2' ' A' ' 55' ' ' PHE . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.538 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 5' ' ' PHE . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.56 ' CG2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' N ' HD22 ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 HG22 ' CG ' ' A' ' 22' ' ' PRO . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.687 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.583 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.631 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.589 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.605 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.599 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HB2' HD23 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.617 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.617 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.711 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.63 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -70.19 109.06 4.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.39 162.65 18.38 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.456 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -111.52 110.68 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 6' ' ' SER . 2.8 m-20 -112.99 155.95 23.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 mt -97.51 -56.89 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 -85.82 15.5 4.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 6' ' ' SER . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 44.3 m-70 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.497 ' N ' HD13 ' A' ' 39' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' HD13 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.57 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 43' ' ' ALA . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 24' ' ' MET . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' O ' ' CD ' ' A' ' 27' ' ' ARG . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.511 ' CB ' HD11 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 55' ' ' PHE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.551 ' HA ' ' ND2' ' A' ' 32' ' ' ASN . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 61' ' ' HIS . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.505 HD11 ' CD2' ' A' ' 5' ' ' PHE . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.556 ' CG2' HD22 ' A' ' 15' ' ' LEU . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' CG ' ' A' ' 22' ' ' PRO . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.691 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.607 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.607 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.615 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.525 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.629 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.629 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.621 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' N ' HG22 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 0.4 OUTLIER -54.91 132.76 47.35 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.8 -172.63 20.1 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' CA ' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.528 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 t -70.48 138.11 50.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.46 113.79 27.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 65' ' ' ALA . 22.0 mt -81.81 -24.52 35.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.721 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 -86.09 16.15 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.778 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 13.1 m-70 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' N ' HD13 ' A' ' 39' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 72' ' ' PRO . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 55' ' ' PHE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.519 ' CB ' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 55' ' ' PHE . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 HG21 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.597 HG22 ' CD2' ' A' ' 61' ' ' HIS . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.534 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 22' ' ' PRO . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.676 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.581 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.607 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.638 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.552 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.634 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.637 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.721 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.634 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HB3' ' CG2' ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -64.8 105.9 1.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.43 169.45 30.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.806 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 t -53.0 109.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -114.41 97.12 6.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.86 . . . . 0.0 109.813 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.56 -10.77 50.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.182 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.717 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.6 m-30 -85.96 17.05 3.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.54 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 14.0 m-70 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.521 ' N ' HD13 ' A' ' 39' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 13' ' ' ASP . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' C ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.625 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 55' ' ' PHE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.525 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' CE2' ' A' ' 55' ' ' PHE . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.651 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.554 HG23 ' CD1' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.521 ' HE2' ' CB ' ' A' ' 79' ' ' LYS . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' A' ' 5' ' ' PHE . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' CG2' ' A' ' 26' ' ' VAL . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.472 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.545 HG21 ' CG ' ' A' ' 22' ' ' PRO . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.69 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.651 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.607 ' HB ' ' CD2' ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.603 ' O ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.552 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HB2' HD21 ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.69 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.62 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.717 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.624 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' CB ' ' HE2' ' A' ' 33' ' ' MET . 0.0 OUTLIER -62.95 119.35 9.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.01 -172.08 12.52 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 2' ' ' THR . 15.1 t -74.32 113.65 11.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -101.25 143.11 31.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.82 -37.04 86.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.2 m-30 -86.44 16.08 4.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 17.5 m-70 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' ASP . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD2' HG23 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.619 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 55' ' ' PHE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.526 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG13 ' CE2' ' A' ' 55' ' ' PHE . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 61' ' ' HIS . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.514 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 5' ' ' PHE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.542 HG23 ' CD2' ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.542 HG21 ' CB ' ' A' ' 22' ' ' PRO . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.675 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' HG23 ' A' ' 23' ' ' VAL . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' ' HB2' ' A' ' 22' ' ' PRO . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.592 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 67' ' ' GLU . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.512 ' CB ' HD21 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.634 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.723 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.617 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.537 ' HB3' ' CG2' ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.561 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt -67.69 107.64 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.78 167.9 28.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 117.969 -1.461 . . . . 0.0 109.54 179.87 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 p -89.23 121.79 31.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.5 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.04 145.49 41.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mt -73.63 -6.06 44.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.713 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.1 m-30 -86.48 16.62 4.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 6' ' ' SER . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 16.8 m-70 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.532 ' N ' HD11 ' A' ' 39' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.543 ' N ' HD13 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' LEU . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD22 ' CB ' ' A' ' 72' ' ' PRO . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.626 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG13 ' CD2' ' A' ' 55' ' ' PHE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.536 ' CB ' HD11 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 HG12 ' CE2' ' A' ' 55' ' ' PHE . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.638 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.569 ' HA ' ' ND2' ' A' ' 32' ' ' ASN . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 27' ' ' ARG . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 29' ' ' THR . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.556 HG21 ' CD2' ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.533 HG23 ' CG ' ' A' ' 22' ' ' PRO . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.667 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.638 ' CZ ' ' CD ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.612 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.612 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.589 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.589 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.561 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.667 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.628 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.635 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.536 ' N ' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.15 137.47 57.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.13 -172.54 27.49 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.6 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.5 p -111.0 109.31 19.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.23 130.99 34.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 65' ' ' ALA . 95.8 mt -72.11 -32.08 66.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.72 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 3.4 m-30 -87.26 16.26 5.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 109.782 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 6' ' ' SER . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 15.0 m-70 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.514 ' N ' HD12 ' A' ' 39' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' CG2' ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD23 ' CB ' ' A' ' 72' ' ' PRO . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 55' ' ' PHE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.545 ' CB ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 55' ' ' PHE . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.634 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' O ' ' HG3' ' A' ' 33' ' ' MET . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 10' ' ' HIS . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 26' ' ' VAL . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' N ' HD21 ' A' ' 15' ' ' LEU . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 22' ' ' PRO . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.662 ' CG2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.634 ' CZ ' ' HG2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' SG ' ' CD1' ' A' ' 77' ' ' ILE . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.608 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD2' ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG1' ' CD2' ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.634 ' CB ' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.588 ' CG ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.627 ' CD2' ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' CB ' HD23 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.662 ' CD2' ' CG2' ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.645 ' CD1' ' O ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.72 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.628 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HD3' ' CD2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -50.81 151.47 2.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.04 -172.45 35.8 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.087 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.4 m80 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 42' ' ' ILE . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.536 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 51' ' ' ASP . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.682 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.042 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.799 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.639 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.799 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.88 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.756 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.832 ' SG ' HG21 ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.106 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.087 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.88 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.665 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.106 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.832 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.891 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.084 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CG ' ' OE2' ' A' ' 37' ' ' GLU . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.629 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.5 m80 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 12' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.976 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.069 HD21 HG22 ' A' ' 42' ' ' ILE . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.708 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 52' ' ' ILE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.724 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG23 ' CD2' ' A' ' 12' ' ' LEU . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.857 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG13 ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.976 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.069 HG22 HD21 ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.806 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.806 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 23' ' ' VAL . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.745 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.71 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.719 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.689 ' NE2' HG13 ' A' ' 30' ' ' VAL . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.096 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.103 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.084 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.096 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.701 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.103 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.648 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.075 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 37' ' ' GLU . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.601 ' CB ' HD12 ' A' ' 39' ' ' LEU . 28.5 m80 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 12' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.858 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.024 HD21 HG22 ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 51' ' ' ASP . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.751 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.752 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.848 HG22 ' HE3' ' A' ' 79' ' ' LYS . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.554 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.829 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.024 HG22 HD21 ' A' ' 15' ' ' LEU . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.766 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.766 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.882 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.797 ' HB3' HG21 ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.657 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.774 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 26' ' ' VAL . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.575 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.799 ' HE1' ' CG1' ' A' ' 30' ' ' VAL . 26.4 m170 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.085 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.1 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.075 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.085 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.882 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.1 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.716 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.89 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.848 ' HE3' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' PHE . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 30.2 m80 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 12' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.987 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.687 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.023 HD21 HG22 ' A' ' 42' ' ' ILE . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.583 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HD23 ' A' ' 12' ' ' LEU . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 41' ' ' ILE . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.023 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.762 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.762 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.73 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.772 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.808 ' SG ' HG11 ' A' ' 26' ' ' VAL . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.627 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.627 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.073 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.084 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.073 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.776 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.741 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.084 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.646 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.611 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.8 m80 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.651 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.736 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.784 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.828 HG23 ' CD2' ' A' ' 12' ' ' LEU . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.776 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.929 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.824 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.864 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 23' ' ' VAL . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.8 ' SG ' HG11 ' A' ' 26' ' ' VAL . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.093 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.654 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.864 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.681 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.093 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.753 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.043 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.651 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.7 m80 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 12' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.975 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.915 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.567 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 56' ' ' CYS . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.558 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.878 HD23 HD11 ' A' ' 41' ' ' ILE . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.975 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.769 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.769 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.897 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.853 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.081 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.043 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.897 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.786 ' HG3' HG23 ' A' ' 42' ' ' ILE . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.081 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.063 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 28.2 m80 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.994 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.913 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.909 HD21 HG22 ' A' ' 42' ' ' ILE . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.832 HG22 ' HA ' ' A' ' 52' ' ' ILE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.707 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.841 HG22 HD13 ' A' ' 41' ' ' ILE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.578 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 41' ' ' ILE . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.817 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.817 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.888 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 23' ' ' VAL . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.832 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.777 ' SG ' HG11 ' A' ' 26' ' ' VAL . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.087 ' CG1' HD23 ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.063 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.888 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.707 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.087 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.879 ' H ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.558 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 37' ' ' GLU . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.3 m80 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 12' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.637 ' N ' HD12 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 42' ' ' ILE . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.72 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.781 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.902 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.557 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.557 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.902 HD13 HG21 ' A' ' 29' ' ' THR . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.923 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.838 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.652 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.838 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.879 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 23' ' ' VAL . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.705 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.755 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.637 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.054 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.078 ' CG1' HD23 ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.054 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.879 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.813 ' HG3' HG23 ' A' ' 42' ' ' ILE . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.653 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.078 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' SG ' ' A' ' 56' ' ' CYS . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.7 m80 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 12' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.92 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.626 ' N ' HD12 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.012 HD21 HG22 ' A' ' 42' ' ' ILE . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.812 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.012 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.771 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.877 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.784 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.797 ' SG ' HG21 ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.076 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.076 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.877 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.731 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.797 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.908 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.608 ' CB ' HD12 ' A' ' 39' ' ' LEU . 33.7 m80 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.989 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.888 HD21 HG22 ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.746 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.82 HG22 ' HA ' ' A' ' 52' ' ' ILE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.711 ' HB3' HD13 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.849 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.566 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.51 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.852 HD23 HD11 ' A' ' 41' ' ' ILE . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.989 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.904 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.839 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.839 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.884 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.558 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.8 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 26' ' ' VAL . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.615 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.099 ' CG1' HD23 ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.884 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.099 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.727 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.884 ' H ' HG23 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.044 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.031 0.443 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.593 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.6 m80 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 12' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.88 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' N ' HD12 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.571 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 52' ' ' ILE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.721 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.864 HG23 ' CD2' ' A' ' 12' ' ' LEU . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.68 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 41' ' ' ILE . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.926 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.82 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.82 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.719 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.855 ' SG ' HG11 ' A' ' 26' ' ' VAL . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.596 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.021 HD21 ' CG ' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.08 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.021 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.8 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.676 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.08 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.715 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.895 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.101 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.099 0.476 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.567 ' CB ' HD12 ' A' ' 39' ' ' LEU . 27.7 m80 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.945 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 42' ' ' ILE . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.712 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.733 ' HB3' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 HD23 ' A' ' 12' ' ' LEU . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.778 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 HG21 ' A' ' 29' ' ' THR . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.945 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.775 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.56 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.803 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' OD2' ' A' ' 45' ' ' ASP . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB3' HG21 ' A' ' 23' ' ' VAL . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 23' ' ' VAL . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.744 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.796 ' SG ' HG11 ' A' ' 26' ' ' VAL . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.922 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.09 ' CG1' HD23 ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.101 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.922 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.789 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.703 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.09 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.861 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.073 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.5 m-30 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 30.0 m80 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.632 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 HG22 ' A' ' 42' ' ' ILE . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.704 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.563 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.76 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.084 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.764 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.771 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.807 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.072 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.11 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.073 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.072 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.729 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.11 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.901 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.018 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.076 0.465 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' OD2' ' HG2' ' A' ' 37' ' ' GLU . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.7 m80 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.972 ' HB3' HG23 ' A' ' 41' ' ' ILE . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.79 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.729 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 52' ' ' ILE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.819 HG11 ' SG ' ' A' ' 56' ' ' CYS . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.585 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.75 HD13 HG21 ' A' ' 29' ' ' THR . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.932 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.85 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.601 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.85 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.862 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.911 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.819 ' SG ' HG11 ' A' ' 26' ' ' VAL . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.083 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.074 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.018 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.083 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.862 ' CD2' HG22 ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.922 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.074 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.907 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.926 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.47 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CB ' HD12 ' A' ' 39' ' ' LEU . 58.5 m80 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 12' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.986 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.666 ' N ' HD12 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.928 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.581 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' PRO . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.702 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.953 HG22 ' HA ' ' A' ' 52' ' ' ILE . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.878 HG22 HD13 ' A' ' 41' ' ' ILE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.642 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.665 ' CG2' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 41' ' ' ILE . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.986 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.928 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.848 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.953 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.037 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.037 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.892 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.683 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.894 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.644 ' HE3' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.09 0.471 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.2 m80 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 12' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.064 HD21 HG22 ' A' ' 42' ' ' ILE . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.55 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.689 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 52' ' ' ILE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.681 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.893 HG23 HD23 ' A' ' 12' ' ' LEU . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.635 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 26' ' ' VAL . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.064 HG22 HD21 ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.786 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.892 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.738 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.772 ' SG ' HG11 ' A' ' 26' ' ' VAL . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.032 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.032 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.892 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.899 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.966 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.6 m-30 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 27.0 m80 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 12' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.773 HD21 ' HB ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.705 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 52' ' ' ILE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.696 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.661 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.896 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.896 HD13 HG21 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.882 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.882 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.867 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.893 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.72 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.778 ' SG ' HG11 ' A' ' 26' ' ' VAL . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.624 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.624 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.049 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.076 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.966 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.049 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.867 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.932 ' HG3' HG23 ' A' ' 42' ' ' ILE . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.686 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.076 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.677 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.08 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.078 0.466 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' PHE . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.676 ' CB ' HD12 ' A' ' 39' ' ' LEU . 31.9 m80 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.642 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.02 HD21 HG22 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.698 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 30' ' ' VAL . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.808 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.576 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.524 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 ' H ' ' A' ' 41' ' ' ILE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.897 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.02 HG22 HD21 ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.826 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 47' ' ' ALA . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.766 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.857 ' SG ' HG11 ' A' ' 26' ' ' VAL . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.093 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.08 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.093 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.719 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.008 0.432 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.631 ' CB ' HD12 ' A' ' 39' ' ' LEU . 30.2 m80 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.99 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.083 HD21 HG22 ' A' ' 42' ' ' ILE . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.643 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 HD23 ' A' ' 12' ' ' LEU . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.756 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 26' ' ' VAL . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 1.1 p-10 -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD23 HD11 ' A' ' 41' ' ' ILE . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.99 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.083 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.813 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.656 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.813 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.806 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG21 ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.633 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.092 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.102 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.873 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.092 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.806 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.897 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.091 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.063 0.459 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.585 ' CB ' HD12 ' A' ' 39' ' ' LEU . 29.0 m80 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.867 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.598 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.043 HD21 ' CG2' ' A' ' 42' ' ' ILE . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.867 HG23 ' CD2' ' A' ' 12' ' ' LEU . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.759 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.827 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.043 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.63 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.776 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.876 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.801 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.725 ' SG ' HG11 ' A' ' 26' ' ' VAL . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.628 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.097 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.091 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.822 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.876 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.753 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.097 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.639 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.915 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.797 ' HD2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.87 156.95 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.35 109.39 16.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 16.7 mt -96.74 -5.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.087 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 -86.9 16.52 4.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.717 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.4 m80 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 42' ' ' ILE . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.536 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 51' ' ' ASP . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.682 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.042 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.799 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.639 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.799 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.88 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.756 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.832 ' SG ' HG21 ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.106 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.087 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.88 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.665 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.106 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.832 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.891 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm -58.8 132.61 54.42 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -178.05 -172.48 42.53 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.3 p -106.47 120.47 42.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -65.84 133.15 50.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 30.6 mt -78.43 -17.58 56.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.084 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.77 16.22 5.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.912 . . . . 0.0 109.73 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CG ' ' OE2' ' A' ' 37' ' ' GLU . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.629 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.5 m80 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 12' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.976 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.069 HD21 HG22 ' A' ' 42' ' ' ILE . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 52' ' ' ILE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.724 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG23 ' CD2' ' A' ' 12' ' ' LEU . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.857 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG13 ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.976 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.069 HG22 HD21 ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.806 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.806 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 23' ' ' VAL . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.745 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.71 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.719 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.689 ' NE2' HG13 ' A' ' 30' ' ' VAL . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.096 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.103 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.084 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.096 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.701 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.103 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.648 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -64.61 106.66 1.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.45 168.37 28.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.538 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -103.55 114.7 29.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.57 132.96 38.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 73.5 mt -67.6 -24.99 65.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.075 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.64 16.05 5.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 37' ' ' GLU . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.601 ' CB ' HD12 ' A' ' 39' ' ' LEU . 28.5 m80 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 12' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.858 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.024 HD21 HG22 ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 51' ' ' ASP . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.751 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.752 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.848 HG22 ' HE3' ' A' ' 79' ' ' LYS . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.554 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.829 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.024 HG22 HD21 ' A' ' 15' ' ' LEU . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.766 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.766 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.882 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' HB3' HG21 ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.657 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.774 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 26' ' ' VAL . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.575 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.799 ' HE1' ' CG1' ' A' ' 30' ' ' VAL . 26.4 m170 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.085 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.1 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.075 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.085 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.882 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.1 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.716 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.89 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.848 ' HE3' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -53.73 142.06 24.64 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . -171.99 -172.74 38.2 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.982 -1.454 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mtt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.0 m -110.14 121.7 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -96.83 128.59 43.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 64' ' ' VAL . 18.1 mt -80.33 -28.77 38.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.88 15.38 4.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -0.923 . . . . 0.0 109.686 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' PHE . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 30.2 m80 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 12' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.987 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.687 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.023 HD21 HG22 ' A' ' 42' ' ' ILE . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.583 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HD23 ' A' ' 12' ' ' LEU . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 41' ' ' ILE . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.023 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.762 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.762 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.73 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.772 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.808 ' SG ' HG11 ' A' ' 26' ' ' VAL . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.627 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.073 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.084 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.073 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.776 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.741 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.084 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.646 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt -58.51 135.11 57.22 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.08 -172.6 41.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 2' ' ' THR . 2.5 t -61.53 108.06 0.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.97 135.86 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.528 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 30.3 mt -72.93 -2.89 22.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.98 16.59 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.576 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.611 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.8 m80 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.651 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.736 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.784 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.828 HG23 ' CD2' ' A' ' 12' ' ' LEU . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.776 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.929 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.824 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.864 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 23' ' ' VAL . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.8 ' SG ' HG11 ' A' ' 26' ' ' VAL . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.093 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.654 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.864 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.681 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.093 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.753 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER -58.03 138.71 55.73 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -177.95 -172.53 42.5 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.65 138.22 35.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 100.5 8.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 5.4 mt -69.72 -6.26 30.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.043 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.54 17.48 3.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -0.822 . . . . 0.0 109.893 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.651 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.7 m80 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 12' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.975 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.915 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 56' ' ' CYS . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.558 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.878 HD23 HD11 ' A' ' 41' ' ' ILE . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.975 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.769 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.769 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.897 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.853 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.081 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.043 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.897 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.786 ' HG3' HG23 ' A' ' 42' ' ' ILE . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.081 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.95 129.54 42.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -147.44 -172.23 17.37 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.12 105.67 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -113.41 118.04 33.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.688 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 27.2 mt -68.98 -9.33 51.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.063 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.45 16.79 4.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.852 . . . . 0.0 109.835 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 28.2 m80 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.994 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.913 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.909 HD21 HG22 ' A' ' 42' ' ' ILE . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.832 HG22 ' HA ' ' A' ' 52' ' ' ILE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.707 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.841 HG22 HD13 ' A' ' 41' ' ' ILE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.578 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 41' ' ' ILE . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.817 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.817 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.888 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 23' ' ' VAL . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.832 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.777 ' SG ' HG11 ' A' ' 26' ' ' VAL . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.087 ' CG1' HD23 ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.063 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.888 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.707 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.087 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.879 ' H ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? -59.73 135.54 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.76 -172.59 36.47 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.339 0.59 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -106.61 126.02 51.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.471 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -101.67 105.88 16.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.541 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 29.8 mt -73.07 -24.62 60.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -87.04 16.04 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.603 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.558 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 37' ' ' GLU . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 25.3 m80 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 12' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.637 ' N ' HD12 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 42' ' ' ILE . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.781 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.902 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.557 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.557 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.902 HD13 HG21 ' A' ' 29' ' ' THR . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.923 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.838 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.652 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.838 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.879 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 23' ' ' VAL . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.705 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.755 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.637 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.054 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.078 ' CG1' HD23 ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.054 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.879 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.813 ' HG3' HG23 ' A' ' 42' ' ' ILE . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.653 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.078 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' SG ' ' A' ' 56' ' ' CYS . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -59.67 106.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.5 166.9 26.34 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.586 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.7 p -94.9 160.4 14.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -109.74 97.55 7.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 4.5 mt -80.34 -25.79 39.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.65 16.28 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.609 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.7 m80 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 12' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.92 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.626 ' N ' HD12 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.012 HD21 HG22 ' A' ' 42' ' ' ILE . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.812 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.012 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.771 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.877 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.784 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.797 ' SG ' HG21 ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.076 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.076 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.877 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.731 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.797 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.908 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? -59.69 133.48 56.13 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.523 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . 179.91 -172.27 43.84 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.534 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.6 m -77.21 123.63 26.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.38 137.61 42.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 24.1 mt -83.31 -8.1 59.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.481 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.24 16.25 4.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' CB ' HD12 ' A' ' 39' ' ' LEU . 33.7 m80 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.989 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.888 HD21 HG22 ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.746 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.82 HG22 ' HA ' ' A' ' 52' ' ' ILE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.711 ' HB3' HD13 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.849 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.566 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.51 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.852 HD23 HD11 ' A' ' 41' ' ' ILE . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.989 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.904 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.839 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.839 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.884 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.558 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.8 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 26' ' ' VAL . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.615 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.099 ' CG1' HD23 ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.884 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.099 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.727 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.884 ' H ' HG23 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -69.73 110.82 5.11 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.31 160.11 13.09 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.547 179.873 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 t -55.26 160.68 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.428 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.09 118.79 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 50.3 mt -89.75 -0.99 57.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.044 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.32 16.51 3.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.875 . . . . 0.0 109.914 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.593 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.6 m80 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 12' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.88 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' N ' HD12 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.571 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 52' ' ' ILE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.721 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.864 HG23 ' CD2' ' A' ' 12' ' ' LEU . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.68 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 41' ' ' ILE . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.926 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.82 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.82 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.719 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.855 ' SG ' HG11 ' A' ' 26' ' ' VAL . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.596 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.021 HD21 ' CG ' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.08 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.021 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.8 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.08 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.715 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.895 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? -57.61 132.49 53.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -138.6 -172.32 12.51 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA3' ' CD ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -61.89 159.43 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.69 154.97 36.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.512 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 20.6 mt -98.71 -40.41 8.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.101 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.51 16.01 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.162 -0.961 . . . . 0.0 109.751 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.567 ' CB ' HD12 ' A' ' 39' ' ' LEU . 27.7 m80 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.945 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 42' ' ' ILE . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.712 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.733 ' HB3' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 HD23 ' A' ' 12' ' ' LEU . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.778 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 HG21 ' A' ' 29' ' ' THR . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.945 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.775 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.56 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.803 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' OD2' ' A' ' 45' ' ' ASP . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB3' HG21 ' A' ' 23' ' ' VAL . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 23' ' ' VAL . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.744 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.796 ' SG ' HG11 ' A' ' 26' ' ' VAL . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.922 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.09 ' CG1' HD23 ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.101 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.922 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.789 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.703 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.09 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.861 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm -56.62 129.57 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.01 -172.62 36.68 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.294 0.568 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.33 160.47 15.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.69 97.23 11.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.513 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 22.1 mt -98.86 -11.75 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.073 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.5 m-30 -86.53 16.1 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.392 -0.818 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 30.0 m80 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.632 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 HG22 ' A' ' 42' ' ' ILE . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.704 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.563 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.76 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.084 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.764 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.771 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.807 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.072 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.11 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.073 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.072 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.729 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.11 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.901 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.65 106.19 0.93 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.27 167.68 27.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.445 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -52.75 160.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.58 107.34 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.663 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 39.2 mt -93.31 -9.29 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.018 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.83 16.37 4.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.762 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' OD2' ' HG2' ' A' ' 37' ' ' GLU . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CB ' HD12 ' A' ' 39' ' ' LEU . 24.7 m80 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.972 ' HB3' HG23 ' A' ' 41' ' ' ILE . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.79 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.729 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 52' ' ' ILE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.819 HG11 ' SG ' ' A' ' 56' ' ' CYS . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.585 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD13 HG21 ' A' ' 29' ' ' THR . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.932 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.85 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.601 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.85 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.862 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.911 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.819 ' SG ' HG11 ' A' ' 26' ' ' VAL . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.083 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.074 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.018 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.083 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.862 ' CD2' HG22 ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.922 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.074 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.907 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -70.19 109.06 4.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.39 162.65 18.38 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.456 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -111.52 110.68 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 6' ' ' SER . 2.8 m-20 -112.99 155.95 23.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 11.7 mt -97.51 -56.89 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.926 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -85.82 15.5 4.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 3' ' ' ASP . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CB ' HD12 ' A' ' 39' ' ' LEU . 58.5 m80 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 12' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.986 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.666 ' N ' HD12 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.928 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' PRO . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.702 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.953 HG22 ' HA ' ' A' ' 52' ' ' ILE . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.878 HG22 HD13 ' A' ' 41' ' ' ILE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.642 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.665 ' CG2' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 41' ' ' ILE . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.986 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.928 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.848 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.953 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.037 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.037 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.892 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.683 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.894 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.644 ' HE3' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -54.91 132.76 47.35 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.8 -172.63 20.1 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' CA ' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.528 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 2' ' ' THR . 2.1 t -70.48 138.11 50.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.46 113.79 27.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 22.0 mt -81.81 -24.52 35.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.09 16.15 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.778 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 26.2 m80 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 12' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.064 HD21 HG22 ' A' ' 42' ' ' ILE . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.55 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.689 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 52' ' ' ILE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.681 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.893 HG23 HD23 ' A' ' 12' ' ' LEU . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.635 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 26' ' ' VAL . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.064 HG22 HD21 ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.786 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.892 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.738 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.772 ' SG ' HG11 ' A' ' 26' ' ' VAL . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.032 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.032 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.892 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -64.8 105.9 1.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.43 169.45 30.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.806 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' THR . 1.1 t -53.0 109.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -114.41 97.12 6.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.86 . . . . 0.0 109.813 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 75.5 mt -87.56 -10.77 50.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.182 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.966 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.6 m-30 -85.96 17.05 3.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 27.0 m80 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 12' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.773 HD21 ' HB ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.705 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 52' ' ' ILE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.696 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.661 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.896 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.896 HD13 HG21 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.882 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.882 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.867 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.893 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.72 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.778 ' SG ' HG11 ' A' ' 26' ' ' VAL . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.624 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.624 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.049 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.076 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.966 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.049 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.867 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.932 ' HG3' HG23 ' A' ' 42' ' ' ILE . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.686 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.076 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.677 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -62.95 119.35 9.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.01 -172.08 12.52 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 2' ' ' THR . 15.1 t -74.32 113.65 11.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.25 143.11 31.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 59.6 mt -64.82 -37.04 86.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.08 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.44 16.08 4.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' PHE . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.676 ' CB ' HD12 ' A' ' 39' ' ' LEU . 31.9 m80 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.642 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.02 HD21 HG22 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.698 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 30' ' ' VAL . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.808 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.576 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.524 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 ' H ' ' A' ' 41' ' ' ILE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.897 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.02 HG22 HD21 ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.826 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 47' ' ' ALA . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.766 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.857 ' SG ' HG11 ' A' ' 26' ' ' VAL . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.093 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.08 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.093 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.719 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt -67.69 107.64 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.78 167.9 28.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 117.969 -1.461 . . . . 0.0 109.54 179.87 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 p -89.23 121.79 31.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.5 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.04 145.49 41.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 4.8 mt -73.63 -6.06 44.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.48 16.62 4.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.631 ' CB ' HD12 ' A' ' 39' ' ' LEU . 30.2 m80 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.99 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.083 HD21 HG22 ' A' ' 42' ' ' ILE . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.643 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 HD23 ' A' ' 12' ' ' LEU . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.756 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 26' ' ' VAL . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 1.1 p-10 -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD23 HD11 ' A' ' 41' ' ' ILE . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.99 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.083 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.813 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.656 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.813 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.806 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG21 ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.633 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.092 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.102 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.873 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.092 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.806 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.897 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.15 137.47 57.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . -160.13 -172.54 27.49 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.6 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.5 p -111.0 109.31 19.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.23 130.99 34.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.587 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 95.8 mt -72.11 -32.08 66.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.091 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 -87.26 16.26 5.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 109.782 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.585 ' CB ' HD12 ' A' ' 39' ' ' LEU . 29.0 m80 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.867 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.598 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.043 HD21 ' CG2' ' A' ' 42' ' ' ILE . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG23 ' CD2' ' A' ' 12' ' ' LEU . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.759 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.827 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.043 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.63 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.776 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.876 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.801 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.725 ' SG ' HG11 ' A' ' 26' ' ' VAL . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.628 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.097 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.091 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.822 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.876 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.753 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.097 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.639 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.915 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.797 ' HD2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -50.81 151.47 2.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.04 -172.45 35.8 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.087 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.2 m-70 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 42' ' ' ILE . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.536 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 51' ' ' ASP . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.682 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.042 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.799 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.639 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.799 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.88 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.756 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.832 ' SG ' HG21 ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.106 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.087 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.88 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.665 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.106 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.832 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.891 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.084 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.629 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.4 m-70 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 12' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.976 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.069 HD21 HG22 ' A' ' 42' ' ' ILE . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.708 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 52' ' ' ILE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.724 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG23 ' CD2' ' A' ' 12' ' ' LEU . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.857 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG13 ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.976 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.069 HG22 HD21 ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.806 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.806 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 23' ' ' VAL . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.745 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.71 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.719 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.689 ' NE2' HG13 ' A' ' 30' ' ' VAL . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.096 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.103 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.084 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.096 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.701 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.103 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.648 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.075 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.601 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.7 m-70 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 12' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.858 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.024 HD21 HG22 ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 51' ' ' ASP . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.751 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.752 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.848 HG22 ' HE3' ' A' ' 79' ' ' LYS . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.554 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.829 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.024 HG22 HD21 ' A' ' 15' ' ' LEU . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.766 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.766 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.882 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.797 ' HB3' HG21 ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.657 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.774 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 26' ' ' VAL . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.085 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.1 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.075 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.085 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.882 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.1 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.716 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.89 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.848 ' HE3' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' PHE . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 12' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.987 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.687 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.023 HD21 HG22 ' A' ' 42' ' ' ILE . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.583 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HD23 ' A' ' 12' ' ' LEU . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 41' ' ' ILE . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.023 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.762 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.762 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.73 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.772 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.808 ' SG ' HG11 ' A' ' 26' ' ' VAL . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.627 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.627 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.073 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.084 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.073 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.776 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.741 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.084 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.646 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.611 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.6 m-70 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.651 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.736 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.784 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.828 HG23 ' CD2' ' A' ' 12' ' ' LEU . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.776 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.929 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.824 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.864 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 23' ' ' VAL . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.8 ' SG ' HG11 ' A' ' 26' ' ' VAL . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.093 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.654 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.864 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.681 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.093 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.753 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.043 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.651 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.6 m-70 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 12' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.975 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.915 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.567 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 56' ' ' CYS . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.558 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.878 HD23 HD11 ' A' ' 41' ' ' ILE . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.975 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.769 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.769 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.897 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.853 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.081 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.043 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.897 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.786 ' HG3' HG23 ' A' ' 42' ' ' ILE . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.081 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.063 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.8 m-70 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.994 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.913 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.909 HD21 HG22 ' A' ' 42' ' ' ILE . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.832 HG22 ' HA ' ' A' ' 52' ' ' ILE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.707 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.841 HG22 HD13 ' A' ' 41' ' ' ILE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.578 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 41' ' ' ILE . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.817 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.817 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.888 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 23' ' ' VAL . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.832 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.777 ' SG ' HG11 ' A' ' 26' ' ' VAL . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.087 ' CG1' HD23 ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.063 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.888 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.707 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.087 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.879 ' H ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.558 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.2 m-70 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 12' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.637 ' N ' HD12 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 42' ' ' ILE . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.72 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.781 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.902 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.557 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.557 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.902 HD13 HG21 ' A' ' 29' ' ' THR . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.923 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.838 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.652 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.838 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.879 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 23' ' ' VAL . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.705 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.755 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.637 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.054 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.078 ' CG1' HD23 ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.054 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.879 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.813 ' HG3' HG23 ' A' ' 42' ' ' ILE . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.653 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.078 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' SG ' ' A' ' 56' ' ' CYS . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.7 m-70 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 12' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.92 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.626 ' N ' HD12 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.012 HD21 HG22 ' A' ' 42' ' ' ILE . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.812 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.012 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.771 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.877 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.784 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.797 ' SG ' HG21 ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.076 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.076 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.877 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.731 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.797 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.908 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.608 ' CB ' HD12 ' A' ' 39' ' ' LEU . 18.8 m-70 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.989 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.888 HD21 HG22 ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.746 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.82 HG22 ' HA ' ' A' ' 52' ' ' ILE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.711 ' HB3' HD13 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.849 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.566 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.51 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.852 HD23 HD11 ' A' ' 41' ' ' ILE . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.989 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.904 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.839 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.839 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.884 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.558 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.8 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 26' ' ' VAL . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.615 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.099 ' CG1' HD23 ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.884 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.099 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.727 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.884 ' H ' HG23 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.044 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.031 0.443 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.593 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.0 m-70 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 12' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.88 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' N ' HD12 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.571 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 52' ' ' ILE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.721 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.864 HG23 ' CD2' ' A' ' 12' ' ' LEU . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.68 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 41' ' ' ILE . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.926 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.82 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.82 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.719 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.855 ' SG ' HG11 ' A' ' 26' ' ' VAL . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.596 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.021 HD21 ' CG ' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.08 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.021 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.8 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.676 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.08 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.715 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.895 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.101 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.099 0.476 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.567 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.8 m-70 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.945 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 42' ' ' ILE . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.712 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.733 ' HB3' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 HD23 ' A' ' 12' ' ' LEU . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.778 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 HG21 ' A' ' 29' ' ' THR . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.945 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.775 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.56 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.803 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' OD2' ' A' ' 45' ' ' ASP . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB3' HG21 ' A' ' 23' ' ' VAL . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 23' ' ' VAL . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.744 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.796 ' SG ' HG11 ' A' ' 26' ' ' VAL . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.922 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.09 ' CG1' HD23 ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.101 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.922 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.789 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.703 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.09 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.861 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.073 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.5 m-30 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 16.1 m-70 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.632 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 HG22 ' A' ' 42' ' ' ILE . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.704 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.563 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.76 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.084 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.764 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.771 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.807 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.072 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.11 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.073 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.072 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.729 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.11 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.901 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.018 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.076 0.465 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.4 m-70 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.972 ' HB3' HG23 ' A' ' 41' ' ' ILE . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.79 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.729 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 52' ' ' ILE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.819 HG11 ' SG ' ' A' ' 56' ' ' CYS . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.585 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.75 HD13 HG21 ' A' ' 29' ' ' THR . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.932 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.85 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.601 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.85 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.862 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.911 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.819 ' SG ' HG11 ' A' ' 26' ' ' VAL . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.083 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.074 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.018 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.083 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.862 ' CD2' HG22 ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.922 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.074 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.907 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.926 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.088 0.47 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CB ' HD12 ' A' ' 39' ' ' LEU . 44.3 m-70 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 12' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.986 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.666 ' N ' HD12 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.928 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.581 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' PRO . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.702 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.953 HG22 ' HA ' ' A' ' 52' ' ' ILE . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.878 HG22 HD13 ' A' ' 41' ' ' ILE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.642 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.665 ' CG2' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 41' ' ' ILE . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.986 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.928 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.848 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.953 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.037 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.037 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.892 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.683 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.894 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.644 ' HE3' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.09 0.471 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.1 m-70 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 12' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.064 HD21 HG22 ' A' ' 42' ' ' ILE . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.55 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.689 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 52' ' ' ILE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.681 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.893 HG23 HD23 ' A' ' 12' ' ' LEU . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.635 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 26' ' ' VAL . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.064 HG22 HD21 ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.786 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.892 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.738 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.772 ' SG ' HG11 ' A' ' 26' ' ' VAL . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.032 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.032 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.892 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.899 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.966 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.6 m-30 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.0 m-70 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 12' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.773 HD21 ' HB ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.705 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 52' ' ' ILE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.696 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.661 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.896 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.896 HD13 HG21 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.882 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.882 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.867 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.893 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.72 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.778 ' SG ' HG11 ' A' ' 26' ' ' VAL . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.624 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.624 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.049 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.076 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.966 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.049 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.867 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.932 ' HG3' HG23 ' A' ' 42' ' ' ILE . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.686 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.076 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.677 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.08 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.078 0.466 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' PHE . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.676 ' CB ' HD12 ' A' ' 39' ' ' LEU . 17.5 m-70 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.642 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.02 HD21 HG22 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.698 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 30' ' ' VAL . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.808 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.576 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.524 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 ' H ' ' A' ' 41' ' ' ILE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.897 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.02 HG22 HD21 ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.826 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 47' ' ' ALA . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.766 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.857 ' SG ' HG11 ' A' ' 26' ' ' VAL . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.093 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.08 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.093 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.719 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.576 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.008 0.432 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.631 ' CB ' HD12 ' A' ' 39' ' ' LEU . 16.8 m-70 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.99 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.083 HD21 HG22 ' A' ' 42' ' ' ILE . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.643 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 HD23 ' A' ' 12' ' ' LEU . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.756 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 26' ' ' VAL . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD23 HD11 ' A' ' 41' ' ' ILE . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.99 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.083 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.813 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.656 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.813 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.806 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG21 ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.633 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.092 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.102 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.873 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.092 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.806 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.897 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.091 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.063 0.459 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.585 ' CB ' HD12 ' A' ' 39' ' ' LEU . 15.0 m-70 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.867 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.598 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.043 HD21 ' CG2' ' A' ' 42' ' ' ILE . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.867 HG23 ' CD2' ' A' ' 12' ' ' LEU . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.759 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.827 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 1.043 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.63 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.776 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.876 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.801 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.725 ' SG ' HG11 ' A' ' 26' ' ' VAL . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.628 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.097 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.091 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.822 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.876 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.753 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.097 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.639 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.915 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.797 ' HD2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.87 156.95 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.35 109.39 16.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 16.7 mt -96.74 -5.53 38.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.087 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 -86.9 16.52 4.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.717 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 63.5 m -45.83 174.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 109.205 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.92 104.19 0.4 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.983 -1.073 . . . . 0.0 109.312 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.16 167.58 26.59 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.485 2.124 . . . . 0.0 110.247 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.463 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 51.2 m-20 -83.17 -23.22 33.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.2 m-70 -144.5 174.48 10.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.5 m -145.23 161.33 39.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.107 -0.995 . . . . 0.0 109.463 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.5 tp -145.98 107.53 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 109.777 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 12' ' ' LEU . 48.0 t0 -74.77 135.99 41.72 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.77 17.51 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.768 1.746 . . . . 0.0 107.792 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.042 HD21 HG22 ' A' ' 42' ' ' ILE . 13.7 mt -79.27 107.02 11.73 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.36 -6.28 63.29 Favored Glycine 0 C--N 1.282 -2.431 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -91.87 147.99 22.56 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -143.04 149.33 38.09 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 117.741 -1.583 . . . . 0.0 109.424 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.536 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.1 t -47.04 141.78 5.63 Favored Pre-proline 0 C--N 1.286 -2.176 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.705 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.497 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.87 3.74 69.99 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 O-C-N 123.755 1.397 . . . . 0.0 111.449 -0.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 16.4 mt-10 -52.65 -47.6 93.61 Favored Pre-proline 0 N--CA 1.507 2.421 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.27 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 121.85 1.7 . . . . 0.0 108.133 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 51' ' ' ASP . 47.4 t -47.65 -25.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -75.33 -42.04 55.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.461 -0.774 . . . . 0.0 109.824 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.682 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -60.98 -43.33 98.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.0 109.027 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.49 -27.55 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 108.432 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.47 -59.3 3.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.405 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.43 -37.05 77.09 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.778 0.799 . . . . 0.0 109.226 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -69.43 -34.0 73.8 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.55 -30.4 45.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 23.4 mtp85 -77.17 -30.05 54.75 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.7 p30 -99.9 0.11 40.64 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.19 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.567 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -88.35 175.09 7.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.24 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.3 mt-30 -134.92 153.48 78.64 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -69.92 120.51 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.846 1.697 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.16 11.21 Favored Glycine 0 C--N 1.297 -1.593 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 mm-40 -118.84 -175.06 2.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.949 . . . . 0.0 109.527 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -140.22 155.86 46.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.093 -1.004 . . . . 0.0 110.565 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -144.76 117.41 8.65 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.82 142.04 28.37 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -137.83 129.78 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.989 -1.069 . . . . 0.0 110.948 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.042 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -105.93 160.01 5.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.799 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.96 126.67 2.88 Favored 'General case' 0 C--N 1.28 -2.419 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.016 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.1 p30 -102.72 -24.29 13.75 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.639 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.38 142.01 90.86 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.92 -18.84 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.509 2.14 . . . . 0.0 110.524 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.54 -2.86 58.47 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.227 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.799 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 4.9 p -87.44 -39.49 15.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.044 . . . . 0.0 109.485 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.88 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.14 -31.55 65.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 108.51 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -37.6 10.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.933 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' HB3' HG21 ' A' ' 23' ' ' VAL . 1.5 m-20 -88.15 -45.01 10.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.97 -1.081 . . . . 0.0 112.686 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -54.39 -51.79 74.93 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.684 -1.26 . . . . 0.0 110.775 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -72.7 -49.41 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.212 0 C-N-CA 121.283 1.322 . . . . 0.0 109.961 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.82 -25.03 6.68 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.756 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.34 -52.26 9.46 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.371 -1.076 . . . . 0.0 109.079 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.832 ' SG ' HG21 ' A' ' 77' ' ' ILE . 23.0 m -54.35 -37.4 64.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.893 -1.13 . . . . 0.0 109.993 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -66.67 -32.9 74.52 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.972 -1.08 . . . . 0.0 110.132 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.85 -28.33 61.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 111.341 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.5 mtp -93.11 8.34 40.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.576 -1.327 . . . . 0.0 111.835 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.9 tt0 83.16 25.84 0.12 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.0 110.992 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -97.01 173.82 7.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 mt-10 -123.04 138.35 54.7 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.667 -1.271 . . . . 0.0 110.799 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.4 tp -83.87 101.35 11.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.106 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.0 t -70.78 -48.04 59.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.802 -1.187 . . . . 0.0 110.682 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.087 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -149.11 130.01 14.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.222 -1.549 . . . . 0.0 111.039 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.6 159.79 14.71 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 118.998 -2.314 . . . . 0.0 110.972 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.7 mm-40 -138.12 111.82 8.25 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.565 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -136.59 32.71 2.75 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -78.65 5.06 11.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.548 -0.72 . . . . 0.0 110.047 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.14 126.05 2.7 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.814 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -35.15 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.794 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.74 71.93 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.137 -2.026 . . . . 0.0 108.858 -0.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.88 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.2 m-85 -71.56 165.12 24.56 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.508 -0.745 . . . . 0.0 110.487 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 15.9 mtm180 -148.36 151.81 35.96 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.665 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.45 126.47 8.41 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.736 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.106 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.1 tp -88.85 152.88 21.48 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.832 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -143.83 107.15 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.068 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.891 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.1 ttp85 -72.22 111.73 7.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.139 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.567 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 13.5 tptm -58.8 132.61 54.42 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -178.05 -172.48 42.53 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.3 p -106.47 120.47 42.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.489 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -65.84 133.15 50.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 30.6 mt -78.43 -17.58 56.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.084 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.77 16.22 5.01 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.912 . . . . 0.0 109.73 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.0 t -46.21 174.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 109.064 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -47.25 104.54 0.42 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.032 . . . . 0.0 108.988 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.2 Cg_endo -75.06 165.86 30.35 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.463 2.109 . . . . 0.0 110.434 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 m-20 -79.26 -22.82 44.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.629 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.4 m-70 -145.97 173.92 11.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.338 -0.851 . . . . 0.0 109.509 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 12' ' ' LEU . 54.4 m -145.63 161.56 39.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.976 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.33 107.41 4.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 12' ' ' LEU . 43.7 t0 -74.36 134.96 42.47 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.58 17.72 2.36 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 123.719 1.724 . . . . 0.0 107.665 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.069 HD21 HG22 ' A' ' 42' ' ' ILE . 14.7 mt -77.51 109.85 11.8 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.48 -1.34 75.87 Favored Glycine 0 C--N 1.284 -2.336 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.9 mt -94.56 148.86 21.83 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 17.7 ptt-85 -142.81 148.73 37.6 Favored 'General case' 0 C--N 1.278 -2.52 0 C-N-CA 117.537 -1.665 . . . . 0.0 109.423 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.1 t -47.16 141.4 6.17 Favored Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.709 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.54 69.91 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.697 1.367 . . . . 0.0 111.792 -0.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 7.3 mt-10 -52.82 -47.0 96.49 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.9 Cg_endo -69.78 -63.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.422 0 C-N-CA 121.696 1.598 . . . . 0.0 108.103 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 52' ' ' ILE . 61.8 t -47.1 -25.52 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -72.28 -44.02 63.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.724 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -58.96 -43.92 91.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 109.102 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG23 ' CD2' ' A' ' 12' ' ' LEU . 68.9 t -63.73 -26.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 109.459 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.637 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.1 mmm180 -73.5 -36.66 65.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.922 -1.111 . . . . 0.0 110.503 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 1.1 mmmt -79.24 -30.04 42.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.857 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -77.82 -36.95 49.59 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG13 ' NE2' ' A' ' 61' ' ' HIS . 2.9 t -69.2 -33.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.15 -30.76 60.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 41.0 p30 -101.36 3.75 40.88 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.636 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 37' ' ' GLU . 5.8 mtp -89.86 178.62 6.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.201 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -132.93 153.16 80.89 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.1 Cg_endo -70.56 124.53 10.84 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 121.808 1.672 . . . . 0.0 110.11 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 78' ' ' ARG . . . 103.11 20.94 10.52 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.448 -2.261 . . . . 0.0 107.448 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 9.2 mm-40 -119.66 -175.19 2.91 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.562 -0.963 . . . . 0.0 109.475 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.1 155.36 47.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.055 -1.028 . . . . 0.0 110.599 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -144.5 117.63 8.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.1 tp -87.29 143.78 27.11 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.976 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -139.46 126.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.929 -1.107 . . . . 0.0 111.097 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.069 HG22 HD21 ' A' ' 15' ' ' LEU . 1.6 mt -101.42 160.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.806 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.47 127.44 3.26 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.032 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.563 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -102.61 -27.62 12.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.37 142.34 90.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.9 Cg_endo -77.94 -19.58 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.539 2.16 . . . . 0.0 110.261 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.38 -2.84 58.82 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.762 -0.586 . . . . 0.0 109.933 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.806 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.6 p -88.34 -40.01 13.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 109.214 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.78 -32.19 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -97.07 -38.13 9.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.01 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 23' ' ' VAL . 53.6 m-20 -85.94 -45.91 11.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.917 -1.115 . . . . 0.0 112.738 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.745 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -53.81 -48.97 91.81 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.708 -1.245 . . . . 0.0 110.904 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -73.33 -49.98 0.2 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.14 1.227 . . . . 0.0 109.706 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.45 -25.82 4.69 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.71 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.75 -52.58 8.7 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.318 -1.107 . . . . 0.0 108.736 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.719 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.2 m -51.94 -37.97 54.74 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.955 -1.09 . . . . 0.0 109.664 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.7 m -65.28 -34.86 79.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.403 -0.811 . . . . 0.0 110.616 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -89.68 5.03 47.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.769 -1.207 . . . . 0.0 111.449 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.2 tp10 81.37 25.21 0.24 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.308 -0.87 . . . . 0.0 110.913 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.689 ' NE2' HG13 ' A' ' 30' ' ' VAL . 3.1 m-70 -96.24 174.52 6.85 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.107 -0.995 . . . . 0.0 108.897 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.9 mt-10 -122.56 143.86 49.47 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.877 -1.14 . . . . 0.0 111.147 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.096 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.3 102.01 13.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.103 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.3 t -70.78 -48.53 56.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 110.59 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.084 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.17 130.56 15.7 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.184 -1.572 . . . . 0.0 110.851 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.096 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 160.89 13.95 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 118.882 -2.386 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -138.07 111.65 8.16 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.399 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 p -136.81 32.51 2.7 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.0 OUTLIER -78.1 4.89 11.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.518 -0.739 . . . . 0.0 110.072 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.09 126.46 2.78 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -34.8 146.43 0.16 Allowed Pre-proline 0 C--N 1.283 -2.301 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.718 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.7 Cg_endo -81.63 148.53 71.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.184 -2.007 . . . . 0.0 109.083 -0.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -71.72 165.98 22.89 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.623 -0.673 . . . . 0.0 110.527 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.633 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 8.4 mtp180 -148.8 152.42 36.5 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.701 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -154.18 124.98 7.15 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.893 -179.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.103 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.3 tp -88.89 152.42 21.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.648 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.7 107.72 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 C-N-CA 118.128 -1.429 . . . . 0.0 110.19 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -72.02 112.19 7.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.602 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -64.61 106.66 1.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.45 168.37 28.53 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.538 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -103.55 114.7 29.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 109.492 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.57 132.96 38.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 73.5 mt -67.6 -24.99 65.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.075 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.64 16.05 5.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 5' ' ' PHE . 69.5 m -46.51 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 p -47.28 104.34 0.41 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.989 -1.07 . . . . 0.0 109.149 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.4 170.42 20.33 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.538 2.159 . . . . 0.0 110.44 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 37.9 m-20 -82.91 -22.32 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.601 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.7 m-70 -146.04 173.83 11.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.84 . . . . 0.0 109.371 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 12' ' ' LEU . 36.7 m -145.43 160.68 41.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 109.578 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.858 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.4 tp -147.06 111.48 5.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.39 -0.818 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.1 t70 -79.77 141.69 36.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.94 19.76 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 123.865 1.793 . . . . 0.0 108.108 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.024 HD21 HG22 ' A' ' 42' ' ' ILE . 1.1 mt -81.97 106.54 13.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.7 -3.05 57.38 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.7 mt -94.96 148.92 21.8 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.88 147.03 34.67 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.57 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.12 141.51 6.0 Favored Pre-proline 0 C--N 1.286 -2.156 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.819 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.81 3.69 69.96 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 O-C-N 123.622 1.327 . . . . 0.0 111.668 -0.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.7 mt-10 -52.88 -47.02 96.7 Favored Pre-proline 0 N--CA 1.509 2.5 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.8 Cg_endo -70.28 -61.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.295 -2.284 0 C-N-CA 121.783 1.655 . . . . 0.0 107.921 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 51' ' ' ASP . 74.5 t -48.33 -25.32 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 3.5 mmt -76.43 -40.97 49.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.751 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.12 -44.65 92.03 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -0.941 . . . . 0.0 108.666 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 73.4 t -63.23 -29.98 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.865 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.43 -53.88 41.42 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.283 -0.885 . . . . 0.0 109.634 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 5.7 mtmt -59.95 -46.15 90.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.752 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.61 -33.78 75.69 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.848 HG22 ' HE3' ' A' ' 79' ' ' LYS . 4.2 t -69.88 -28.79 38.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.0 mtt180 -77.03 -29.55 55.32 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.1 p30 -101.28 0.41 37.23 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.257 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.554 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.3 mtp -90.51 179.17 5.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 15.6 mp0 -139.02 152.63 70.48 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 29.4 Cg_endo -70.19 118.22 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.86 1.707 . . . . 0.0 109.73 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.34 21.28 6.63 Favored Glycine 0 C--N 1.294 -1.757 0 N-CA-C 106.987 -2.445 . . . . 0.0 106.987 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 7.3 mp0 -122.84 -175.36 3.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.633 -0.922 . . . . 0.0 109.791 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.7 153.78 49.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.093 -1.005 . . . . 0.0 110.442 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.43 116.48 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 22.3 tp -87.93 142.43 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.779 -1.201 . . . . 0.0 107.897 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.829 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.23 153.18 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.024 HG22 HD21 ' A' ' 15' ' ' LEU . 1.2 mt -127.94 159.8 38.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.766 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 129.29 3.08 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.124 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.3 p30 -104.74 -24.18 12.96 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -61.22 143.21 92.81 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.66 -18.97 13.18 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.401 2.067 . . . . 0.0 110.227 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.09 -2.29 58.08 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.764 -0.585 . . . . 0.0 110.286 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.766 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -86.35 -43.51 12.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 109.413 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.882 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.15 -30.42 49.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.49 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -97.05 -37.51 10.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.729 -0.789 . . . . 0.0 112.297 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' HB3' HG21 ' A' ' 23' ' ' VAL . 19.3 m-20 -89.21 -45.25 9.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.877 -1.139 . . . . 0.0 112.819 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.657 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -54.7 -49.41 91.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.683 -1.26 . . . . 0.0 110.763 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 28.1 Cg_endo -73.82 -50.32 0.18 Allowed 'Trans proline' 0 C--N 1.296 -2.192 0 C-N-CA 121.208 1.272 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.65 -24.47 5.79 Favored Glycine 0 C--N 1.295 -1.703 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.774 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.22 -52.82 8.57 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.367 -1.078 . . . . 0.0 109.007 178.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.847 ' SG ' HG11 ' A' ' 26' ' ' VAL . 25.7 m -55.25 -37.14 66.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.017 -1.052 . . . . 0.0 109.975 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 m -65.96 -32.55 74.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.039 -1.038 . . . . 0.0 109.845 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.61 -29.52 61.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.9 mmt -88.34 6.7 35.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.63 -1.294 . . . . 0.0 111.265 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.575 ' CB ' ' O ' ' A' ' 59' ' ' MET . 27.5 tt0 84.23 23.79 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.45 -0.781 . . . . 0.0 110.385 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.33 173.45 7.37 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.4 OUTLIER -123.3 140.8 52.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.819 -1.176 . . . . 0.0 111.094 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.085 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.7 tp -83.41 101.5 11.4 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.1 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.2 t -71.14 -48.47 54.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.837 -1.164 . . . . 0.0 110.581 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.075 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.19 130.35 15.48 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.283 -1.51 . . . . 0.0 110.882 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.085 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.77 160.95 13.92 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 118.843 -2.411 . . . . 0.0 110.743 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 5.2 mm-40 -138.44 111.74 8.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.369 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 p -136.87 32.77 2.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.77 5.57 10.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.76 127.12 2.86 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -35.43 146.58 0.18 Allowed Pre-proline 0 C--N 1.281 -2.4 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.76 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.1 Cg_endo -81.53 147.97 71.27 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.157 -2.018 . . . . 0.0 108.966 -0.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.882 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.2 m-85 -71.7 165.05 24.81 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.486 -0.759 . . . . 0.0 110.156 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.63 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -147.72 151.62 36.4 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.79 124.54 7.84 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.928 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.1 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.4 tp -88.83 152.32 21.83 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.716 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -144.09 108.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.055 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.89 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.0 ttm180 -72.15 107.71 4.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.808 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.848 ' HE3' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -53.73 142.06 24.64 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . -171.99 -172.74 38.2 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.982 -1.454 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 mtt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.0 m -110.14 121.7 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -96.83 128.59 43.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 64' ' ' VAL . 18.1 mt -80.33 -28.77 38.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.88 15.38 4.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -0.923 . . . . 0.0 109.686 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' PHE . 75.3 m -47.76 175.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 108.719 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.08 104.1 0.39 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 108.881 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.7 Cg_endo -75.16 165.57 30.81 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.125 . . . . 0.0 110.53 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.5 m-20 -76.97 -23.31 52.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.397 -0.814 . . . . 0.0 108.982 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 16.1 m-70 -145.03 172.27 13.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.311 -0.868 . . . . 0.0 109.324 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 12' ' ' LEU . 61.1 m -145.48 161.85 38.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.987 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.1 tp -146.56 107.68 4.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.687 ' N ' HD12 ' A' ' 12' ' ' LEU . 18.5 t70 -74.48 132.57 42.01 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -137.43 16.89 2.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 123.786 1.755 . . . . 0.0 107.339 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.023 HD21 HG22 ' A' ' 42' ' ' ILE . 12.2 mt -78.61 105.56 9.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.25 -5.64 61.1 Favored Glycine 0 C--N 1.282 -2.467 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.574 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.71 147.59 22.88 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.59 147.93 36.67 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 117.783 -1.567 . . . . 0.0 109.52 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.06 141.36 5.95 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.778 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' MET . 43.9 Cg_endo -88.74 3.4 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.647 1.34 . . . . 0.0 111.647 -0.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 10.1 mt-10 -52.21 -47.76 91.24 Favored Pre-proline 0 N--CA 1.509 2.476 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.6 Cg_endo -69.73 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.383 0 C-N-CA 121.782 1.655 . . . . 0.0 108.203 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 55' ' ' PHE . 61.1 t -47.38 -25.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -74.59 -43.05 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.0 109.729 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.583 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 108.996 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG23 HD23 ' A' ' 12' ' ' LEU . 78.5 t -62.71 -27.91 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.656 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -65.8 -57.98 6.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.154 -0.967 . . . . 0.0 109.946 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -63.0 -36.62 84.16 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.605 HG21 HD13 ' A' ' 39' ' ' LEU . 1.2 m -67.61 -33.45 75.02 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.7 t -70.62 -29.66 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 53.0 mtp180 -74.46 -31.45 62.25 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -100.71 3.77 42.57 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.665 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.579 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 7.1 mtp -87.9 169.67 11.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.913 . . . . 0.0 109.531 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.4 mp0 -126.54 152.86 75.02 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.41 120.3 6.87 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.693 1.596 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.74 7.4 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.0 mt-10 -122.0 -174.88 2.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.713 -0.875 . . . . 0.0 109.918 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -138.84 155.49 48.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.352 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 41' ' ' ILE . 3.4 tp -145.8 117.4 8.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.534 -0.729 . . . . 0.0 109.065 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 22.5 tp -87.35 143.93 27.01 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 123.17 21.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.682 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.023 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.02 160.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.762 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.92 126.83 2.93 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.193 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.2 p30 -102.79 -24.26 13.73 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.01 142.67 88.94 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.3 Cg_endo -77.89 -19.28 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.469 2.113 . . . . 0.0 110.458 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.43 -2.27 58.33 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.684 -0.635 . . . . 0.0 110.173 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.762 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.3 p -86.64 -41.8 13.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.029 -1.044 . . . . 0.0 109.526 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.96 -31.7 63.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.99 . . . . 0.0 108.622 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -96.91 -37.31 10.27 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.641 -0.824 . . . . 0.0 112.056 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.6 m-20 -88.55 -45.61 9.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.963 -1.086 . . . . 0.0 112.732 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.73 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.48 -50.85 82.91 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.624 -1.298 . . . . 0.0 110.757 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.8 Cg_endo -73.0 -49.85 0.22 Allowed 'Trans proline' 0 C--N 1.296 -2.215 0 C-N-CA 121.309 1.339 . . . . 0.0 109.961 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.71 -24.81 6.22 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.772 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.53 -52.74 8.55 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.385 -1.068 . . . . 0.0 109.042 178.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.808 ' SG ' HG11 ' A' ' 26' ' ' VAL . 23.4 m -53.82 -37.23 63.35 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.889 -1.132 . . . . 0.0 109.918 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -66.01 -32.53 74.06 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.017 -1.052 . . . . 0.0 109.944 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.97 -30.17 62.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 111.299 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.627 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 5.4 mmt -89.46 6.18 41.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.697 -1.252 . . . . 0.0 111.522 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.561 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.6 mm-40 83.84 26.55 0.1 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.376 -0.828 . . . . 0.0 110.892 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.9 m-70 -96.34 174.27 6.96 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -122.46 140.63 52.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.703 -1.248 . . . . 0.0 110.821 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.073 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.5 tp -85.52 101.6 12.79 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.084 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.7 t -72.26 -49.95 39.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.84 -1.163 . . . . 0.0 110.555 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.14 16.63 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.108 -1.62 . . . . 0.0 110.833 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.073 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.51 160.59 14.17 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 118.905 -2.372 . . . . 0.0 110.807 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 11.0 mm-40 -138.67 111.53 7.78 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.343 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -137.02 32.45 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -78.67 5.6 10.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.684 0.755 . . . . 0.0 110.166 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.2 127.83 2.91 Favored Glycine 0 C--N 1.293 -1.834 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.776 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.82 146.08 0.2 Allowed Pre-proline 0 C--N 1.281 -2.409 0 CA-C-N 115.119 -0.541 . . . . 0.0 110.527 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.586 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 44.4 Cg_endo -81.92 148.45 70.13 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.904 -0.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.0 m-85 -73.15 165.27 25.36 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 121.506 -0.746 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 21.9 mtp180 -148.08 151.64 36.01 Favored 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.741 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.04 123.81 7.33 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.126 -1.03 . . . . 0.0 108.97 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.084 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.6 tp -88.61 151.94 22.15 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.646 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 3.7 mt -143.92 109.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 C-N-CA 118.329 -1.349 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.6 ttp180 -71.86 114.03 9.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.387 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 22.2 tptt -58.51 135.11 57.22 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.08 -172.6 41.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.574 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 2' ' ' THR . 2.5 t -61.53 108.06 0.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.97 135.86 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.528 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 30.3 mt -72.93 -2.89 22.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.98 16.59 4.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.576 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PHE . 46.2 m -45.8 174.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.406 -0.809 . . . . 0.0 109.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -47.06 104.26 0.4 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.51 173.64 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 71.2 m-20 -88.06 -22.71 24.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.027 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.611 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.6 m-70 -143.48 174.15 11.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.412 -0.805 . . . . 0.0 109.257 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.8 m -145.45 160.73 41.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 0.0 109.946 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -148.59 111.9 4.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.483 -0.76 . . . . 0.0 109.759 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.651 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.6 t70 -82.13 140.38 33.82 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.929 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.7 20.23 1.83 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.877 1.799 . . . . 0.0 108.16 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.731 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -82.67 106.72 14.75 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.15 -1.1 57.45 Favored Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.0 mt -96.69 149.93 21.25 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.3 148.35 36.2 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.837 -1.545 . . . . 0.0 109.515 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.8 t -47.33 141.71 6.35 Favored Pre-proline 0 C--N 1.287 -2.121 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.533 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.66 3.48 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 O-C-N 123.632 1.333 . . . . 0.0 111.653 -0.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 12.0 mt-10 -52.7 -47.15 95.38 Favored Pre-proline 0 N--CA 1.509 2.487 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.736 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.1 Cg_endo -69.79 -62.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.157 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 55' ' ' PHE . 32.3 t -47.79 -25.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.23 -41.81 56.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 109.801 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.784 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mmt -60.34 -43.85 96.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.225 -0.922 . . . . 0.0 109.102 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.828 HG23 ' CD2' ' A' ' 12' ' ' LEU . 65.5 t -62.59 -29.03 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.947 . . . . 0.0 108.784 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' CD ' ' CZ ' ' A' ' 55' ' ' PHE . 17.0 mmm180 -67.4 -55.18 14.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.279 -0.888 . . . . 0.0 109.938 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HA ' ' CD ' ' A' ' 31' ' ' ARG . 14.7 ptmt -62.43 -33.7 75.33 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.908 0.861 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.776 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -71.98 -34.31 68.84 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.7 t -69.13 -29.0 41.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 2.7 mtp180 -78.33 -30.6 48.25 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 40.0 p30 -99.04 0.05 42.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.408 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 7.1 mtp -87.37 -179.9 6.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 1.4 mt-30 -136.93 153.53 75.5 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -70.4 120.18 6.93 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.641 1.561 . . . . 0.0 109.481 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.91 26.21 7.19 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.094 -2.402 . . . . 0.0 107.094 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 7.6 mp0 -123.02 -174.48 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.953 . . . . 0.0 110.162 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -139.82 154.04 47.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.837 HD23 HD11 ' A' ' 41' ' ' ILE . 4.1 tp -141.91 117.53 10.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.9 tp -87.53 141.51 28.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.76 -1.213 . . . . 0.0 107.752 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.14 152.81 28.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.068 -1.02 . . . . 0.0 110.694 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.929 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -128.17 163.41 32.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 177.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.23 129.66 2.87 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.203 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 2.0 p30 -103.38 -27.22 12.57 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.42 141.26 91.59 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.62 -18.77 13.38 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.48 2.12 . . . . 0.0 110.368 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.41 -2.74 58.51 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.669 -0.644 . . . . 0.0 110.029 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.824 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.4 p -87.93 -39.99 14.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.864 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.16 -31.36 65.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.12 -0.987 . . . . 0.0 108.342 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -96.76 -37.68 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.065 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' HG21 ' A' ' 23' ' ' VAL . 17.3 m-20 -87.31 -45.84 10.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.97 -1.081 . . . . 0.0 112.81 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 mt -53.91 -48.21 94.47 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.684 -1.26 . . . . 0.0 111.032 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.05 -50.88 0.18 Allowed 'Trans proline' 0 C--N 1.297 -2.135 0 C-N-CA 121.174 1.249 . . . . 0.0 110.057 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.01 -25.39 5.2 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.23 -52.41 10.08 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.417 -1.049 . . . . 0.0 109.129 178.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.8 ' SG ' HG11 ' A' ' 26' ' ' VAL . 17.6 m -54.16 -39.56 66.67 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.79 -1.194 . . . . 0.0 109.733 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.1 m -62.01 -33.59 74.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.069 -1.02 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -70.46 -36.86 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 111.189 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.638 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.3 mmt -84.6 6.95 21.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.725 -1.234 . . . . 0.0 111.42 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 59' ' ' MET . 2.8 mt-10 82.24 26.18 0.17 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.252 -0.905 . . . . 0.0 111.036 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.51 173.79 7.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 108.519 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.3 mt-10 -123.0 141.17 52.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.859 -1.15 . . . . 0.0 110.974 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.091 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.51 101.04 11.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.093 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.0 t -70.71 -48.64 56.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.778 -1.201 . . . . 0.0 110.625 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.74 130.32 15.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.14 -1.6 . . . . 0.0 110.875 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.091 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.69 161.18 13.79 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 118.986 -2.322 . . . . 0.0 110.778 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 9.6 mm-40 -138.4 111.95 8.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.641 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -136.57 31.72 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -78.9 5.01 12.54 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.645 0.736 . . . . 0.0 110.02 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.62 127.08 2.82 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.45 146.46 0.18 Allowed Pre-proline 0 C--N 1.282 -2.361 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.64 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.654 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.4 147.5 71.13 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.171 -2.012 . . . . 0.0 108.883 -0.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.864 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -70.78 164.97 24.09 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.549 -0.719 . . . . 0.0 110.009 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.3 mtm-85 -148.87 152.83 37.14 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.681 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.88 125.39 8.22 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.887 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.093 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.1 tp -88.58 152.08 22.08 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.753 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.58 107.25 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 C-N-CA 118.073 -1.451 . . . . 0.0 110.096 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.9 ttt180 -73.07 115.01 11.87 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.432 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 33' ' ' MET . 0.4 OUTLIER -58.03 138.71 55.73 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . -177.95 -172.53 42.5 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.65 138.22 35.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 100.5 8.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 5.4 mt -69.72 -6.26 30.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.043 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.54 17.48 3.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.385 -0.822 . . . . 0.0 109.893 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.2 t -44.03 175.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.701 . . . . 0.0 109.436 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 6' ' ' SER . 0.7 OUTLIER -46.37 104.3 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.0 109.479 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.1 Cg_endo -75.08 167.2 27.5 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.614 2.209 . . . . 0.0 110.225 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 69.6 m-20 -80.78 -23.82 39.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.191 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.651 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.6 m-70 -145.14 175.8 9.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 0.0 109.237 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 12' ' ' LEU . 58.0 m -145.66 161.82 38.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.011 -1.056 . . . . 0.0 109.575 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.975 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.4 tp -148.1 108.59 4.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.05 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.676 ' N ' HD12 ' A' ' 12' ' ' LEU . 15.9 t70 -75.22 134.71 41.1 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.915 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.78 2.51 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 123.819 1.771 . . . . 0.0 107.797 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -81.18 105.86 12.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.84 -4.06 57.57 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 106.986 -2.446 . . . . 0.0 106.986 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.1 mt -94.94 148.13 22.64 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -143.07 147.2 34.65 Favored 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 117.812 -1.555 . . . . 0.0 109.472 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.08 141.63 5.83 Favored Pre-proline 0 C--N 1.288 -2.093 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.738 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.462 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.3 Cg_endo -88.63 3.57 69.86 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.716 -0.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 42.1 mt-10 -53.12 -46.97 97.46 Favored Pre-proline 0 N--CA 1.509 2.505 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 26.9 Cg_endo -69.52 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.402 0 C-N-CA 121.768 1.646 . . . . 0.0 108.196 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.5 t -46.75 -26.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.6 mmt -74.56 -42.46 58.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.523 -0.736 . . . . 0.0 109.69 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.0 mmt -60.84 -43.06 98.81 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.178 -0.951 . . . . 0.0 109.003 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG11 ' SG ' ' A' ' 56' ' ' CYS . 79.1 t -63.24 -28.78 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 108.768 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.6 -57.84 5.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.412 -0.805 . . . . 0.0 109.46 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -57.43 -35.23 69.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.81 -33.52 70.79 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 t -70.34 -26.98 30.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.2 mtp85 -78.08 -31.55 50.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -100.69 4.72 43.39 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.33 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.558 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.1 mtp -95.68 173.16 7.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 16.6 mm-40 -131.84 153.36 81.41 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.98 123.48 9.74 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.955 1.77 . . . . 0.0 109.732 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 105.15 19.56 10.59 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 107.242 -2.343 . . . . 0.0 107.242 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 8.8 mt-10 -120.51 -175.44 3.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.609 -0.936 . . . . 0.0 109.383 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.61 156.45 48.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 110.313 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.878 HD23 HD11 ' A' ' 41' ' ' ILE . 4.2 tp -145.85 117.46 8.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.157 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 47.1 tp -86.1 147.81 25.99 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.975 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -144.23 121.29 5.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.097 -1.002 . . . . 0.0 110.668 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.0 mt -97.4 163.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.769 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.29 126.68 2.76 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -103.65 -24.56 13.36 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.49 142.51 90.88 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -77.64 -19.13 13.09 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.58 2.187 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.39 -2.45 58.42 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.705 -0.622 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.769 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -86.8 -42.3 13.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.94 -1.1 . . . . 0.0 109.557 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.897 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.19 -32.01 61.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 108.65 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -96.51 -37.33 10.45 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.047 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -88.77 -46.57 8.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.049 -1.032 . . . . 0.0 112.54 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.853 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.16 -51.47 71.45 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.13 . . . . 0.0 111.042 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.4 Cg_endo -71.88 -50.27 0.28 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.123 1.215 . . . . 0.0 109.941 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.64 -24.34 5.66 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.55 -53.39 8.13 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.334 -1.098 . . . . 0.0 108.916 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.873 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.1 m -56.4 -37.02 69.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.005 -1.059 . . . . 0.0 110.408 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -66.56 -32.75 74.3 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.981 -1.074 . . . . 0.0 110.303 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -75.22 -30.32 60.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -0.908 . . . . 0.0 111.128 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 6.5 mmt -85.77 4.83 35.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.65 -1.281 . . . . 0.0 111.184 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 59' ' ' MET . 7.5 tt0 84.84 23.54 0.09 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.6 m-70 -96.45 174.16 7.0 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.8 mm-40 -122.96 140.17 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.636 -1.29 . . . . 0.0 111.355 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.8 tp -84.14 101.6 11.95 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.081 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.9 t -71.35 -48.9 51.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.743 -1.223 . . . . 0.0 110.686 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.043 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.27 130.14 16.2 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.212 -1.555 . . . . 0.0 110.734 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.4 161.24 13.73 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 118.931 -2.356 . . . . 0.0 110.648 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.7 mt-10 -139.25 111.47 7.48 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -136.51 32.99 2.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.55 4.94 12.04 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.648 0.737 . . . . 0.0 110.046 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.71 127.82 2.88 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.7 mt -35.26 145.92 0.19 Allowed Pre-proline 0 C--N 1.281 -2.399 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.797 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -82.19 148.15 68.03 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.149 -2.021 . . . . 0.0 108.87 -0.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.897 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.6 m-85 -72.21 163.08 28.54 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.786 ' HG3' HG23 ' A' ' 42' ' ' ILE . 6.8 mtm180 -146.12 151.22 37.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.43 124.22 8.55 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.023 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.081 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.7 tp -88.32 151.81 22.36 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.6 mt -144.12 108.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.444 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.892 ' H ' HG23 ' A' ' 64' ' ' VAL . 22.5 ttt180 -71.84 109.9 6.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 108.644 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.95 129.54 42.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.347 -0.845 . . . . 0.0 108.783 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -147.44 -172.23 17.37 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.12 105.67 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -113.41 118.04 33.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.688 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 27.2 mt -68.98 -9.33 51.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.063 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.45 16.79 4.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.852 . . . . 0.0 109.835 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 5' ' ' PHE . 74.9 m -44.9 174.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 109.38 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 7' ' ' SER . 20.4 p -46.71 104.08 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.845 -1.159 . . . . 0.0 109.207 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.9 Cg_endo -75.25 166.95 27.86 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.561 2.174 . . . . 0.0 110.429 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 68.6 m-20 -77.28 -22.46 52.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.03 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.8 m-70 -147.93 175.5 10.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.292 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 12' ' ' LEU . 33.6 m -145.62 161.37 39.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.994 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.3 tp -147.3 108.45 4.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.19 -0.944 . . . . 0.0 109.967 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 t70 -75.33 134.65 40.97 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.913 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -140.35 18.72 2.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 123.967 1.841 . . . . 0.0 107.479 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.909 HD21 HG22 ' A' ' 42' ' ' ILE . 10.6 mt -79.38 104.94 10.34 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.284 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.42 -2.21 59.05 Favored Glycine 0 C--N 1.281 -2.496 0 N-CA-C 107.35 -2.3 . . . . 0.0 107.35 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -95.63 148.67 22.28 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -142.69 149.24 38.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.418 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.8 t -47.2 141.47 6.2 Favored Pre-proline 0 C--N 1.286 -2.162 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.741 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 45.2 Cg_endo -88.66 3.11 69.87 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 O-C-N 123.711 1.374 . . . . 0.0 111.653 -0.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mm-40 -51.8 -48.09 88.62 Favored Pre-proline 0 N--CA 1.51 2.534 0 N-CA-C 114.403 1.261 . . . . 0.0 114.403 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.13 -62.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.292 -2.431 0 C-N-CA 121.69 1.594 . . . . 0.0 108.244 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.832 HG22 ' HA ' ' A' ' 52' ' ' ILE . 64.0 t -46.96 -26.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 3.9 mtt -74.16 -43.7 56.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.682 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.707 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.95 -43.73 94.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 108.941 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.841 HG22 HD13 ' A' ' 41' ' ' ILE . 86.4 t -63.37 -25.48 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.233 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -65.64 -60.1 3.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.486 -0.759 . . . . 0.0 109.276 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -59.06 -40.86 86.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -64.05 -36.11 82.94 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.14 -29.08 43.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 59.8 mtp180 -76.35 -30.05 57.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.63 4.31 40.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.327 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.578 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -93.67 179.65 5.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.318 -0.864 . . . . 0.0 109.865 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -139.16 153.09 71.02 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.6 Cg_endo -70.44 119.72 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.735 1.623 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.35 20.22 8.38 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 0.4 OUTLIER -122.26 -175.41 3.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.591 -0.946 . . . . 0.0 109.504 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -138.55 156.88 47.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 110.604 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 41' ' ' ILE . 3.6 tp -145.88 118.05 8.35 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 31.1 tp -86.52 146.37 26.41 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.53 122.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.034 -1.041 . . . . 0.0 110.975 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -99.17 162.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.817 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.82 126.69 2.55 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.73 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.5 p30 -102.41 -24.13 13.87 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.96 142.61 92.62 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.0 Cg_endo -78.06 -19.65 12.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.46 2.107 . . . . 0.0 110.454 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.69 -2.78 58.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.623 -0.673 . . . . 0.0 110.088 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.817 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.9 p -87.25 -40.76 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.028 . . . . 0.0 109.354 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.888 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.44 -33.74 63.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 108.697 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -96.69 -38.11 10.05 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.057 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' HB3' HG21 ' A' ' 23' ' ' VAL . 74.9 m-20 -85.01 -47.06 10.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.014 -1.054 . . . . 0.0 112.662 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.832 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.31 -48.39 89.57 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.805 -1.184 . . . . 0.0 111.183 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.6 Cg_endo -72.71 -50.56 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.178 0 C-N-CA 121.057 1.171 . . . . 0.0 109.923 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.88 -25.0 4.73 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -77.23 -51.87 10.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.266 -1.138 . . . . 0.0 108.89 178.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.777 ' SG ' HG11 ' A' ' 26' ' ' VAL . 35.7 m -55.63 -38.16 69.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.856 -1.153 . . . . 0.0 109.953 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -61.27 -34.92 75.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.107 -0.996 . . . . 0.0 109.928 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.88 -41.51 78.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 40.9 mmm -75.19 2.97 9.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.954 -1.091 . . . . 0.0 111.058 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.7 OUTLIER 79.52 27.42 0.37 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.25 -0.906 . . . . 0.0 109.843 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -95.57 174.16 7.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.6 mt-10 -122.92 143.13 50.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.709 -1.244 . . . . 0.0 111.409 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.1 tp -85.04 101.59 12.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.087 ' CG1' HD23 ' A' ' 76' ' ' LEU . 75.6 t -71.23 -47.9 57.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.856 -1.153 . . . . 0.0 110.722 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.063 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.52 130.12 15.94 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 120.12 -1.613 . . . . 0.0 110.647 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.45 13.63 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.84 -2.413 . . . . 0.0 110.748 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 1.2 mm-40 -138.38 111.55 7.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.551 0.691 . . . . 0.0 109.27 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.6 p -137.44 31.73 2.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.6 m-20 -78.28 5.23 10.84 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.606 0.717 . . . . 0.0 110.025 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.66 125.61 2.65 Favored Glycine 0 C--N 1.292 -1.903 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 73' ' ' TYR . 8.5 mt -36.59 148.08 0.19 Allowed Pre-proline 0 C--N 1.281 -2.382 0 CA-C-O 121.177 0.513 . . . . 0.0 110.626 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.32 148.85 73.98 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.039 -2.067 . . . . 0.0 109.041 -0.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.888 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.2 m-85 -71.96 164.68 25.66 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.605 -0.684 . . . . 0.0 110.723 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -147.14 152.56 38.64 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.707 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.28 124.45 7.48 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.994 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.087 HD23 ' CG1' ' A' ' 64' ' ' VAL . 20.8 tp -88.63 152.01 22.1 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.696 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -143.76 108.7 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 C-N-CA 118.12 -1.432 . . . . 0.0 110.414 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.879 ' H ' HG23 ' A' ' 64' ' ' VAL . 46.2 ttt180 -72.11 109.0 5.6 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.05 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 7.2 tmtt? -59.73 135.54 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 108.786 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.76 -172.59 36.47 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.339 0.59 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 m -106.61 126.02 51.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.471 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -101.67 105.88 16.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.541 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 29.8 mt -73.07 -24.62 60.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -87.04 16.04 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.603 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 48.8 m -46.55 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.357 -0.839 . . . . 0.0 109.296 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -46.91 103.79 0.37 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 108.968 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.558 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.8 Cg_endo -75.63 170.2 20.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.549 2.166 . . . . 0.0 110.291 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 9.6 m-20 -81.6 -23.24 37.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 108.977 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.2 m-70 -145.1 173.37 11.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.309 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.509 HG22 ' N ' ' A' ' 12' ' ' LEU . 60.8 m -145.22 161.52 39.35 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.129 -0.982 . . . . 0.0 109.54 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.0 tp -148.12 110.66 4.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.637 ' N ' HD12 ' A' ' 12' ' ' LEU . 37.2 t70 -80.07 140.6 36.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 19.67 1.65 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.817 1.77 . . . . 0.0 108.345 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 42' ' ' ILE . 2.0 mt -82.63 105.85 14.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.67 -1.62 56.95 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 4.3 mt -97.26 150.1 21.31 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.9 ptt-85 -143.3 148.92 37.08 Favored 'General case' 0 C--N 1.278 -2.527 0 C-N-CA 117.859 -1.537 . . . . 0.0 109.288 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.4 t -47.26 141.78 6.16 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.644 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.7 Cg_endo -88.65 3.62 69.86 Favored 'Cis proline' 0 C--N 1.306 -1.702 0 O-C-N 123.649 1.342 . . . . 0.0 111.67 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 1.4 mm-40 -53.14 -47.34 96.22 Favored Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.2 Cg_endo -69.48 -63.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 C-N-CA 121.739 1.626 . . . . 0.0 108.263 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 55' ' ' PHE . 21.2 t -48.62 -25.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.3 mmm -72.95 -42.76 63.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.44 -0.788 . . . . 0.0 109.875 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.781 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.96 -42.98 95.27 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.6 t -64.09 -29.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.068 -1.02 . . . . 0.0 108.913 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . 6.8 mmt85 -65.83 -53.75 35.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -61.71 -41.61 97.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.902 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.22 -35.3 80.65 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.22 -28.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -77.27 -29.65 53.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.9 p30 -102.36 2.11 36.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.339 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.557 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 10.3 mtp -89.3 170.59 10.44 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.369 -0.832 . . . . 0.0 109.623 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 5.0 mt-30 -131.2 154.25 81.92 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -68.57 124.15 11.26 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.62 1.547 . . . . 0.0 109.6 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.1 10.04 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.557 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 20.4 mt-10 -119.69 -175.11 2.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.87 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -141.21 153.54 45.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 110.457 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.902 HD13 HG21 ' A' ' 29' ' ' THR . 4.4 tp -141.86 116.99 10.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 20.2 tp -87.82 142.53 27.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -138.2 149.87 24.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.697 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.923 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.5 mt -126.14 161.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.838 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.37 128.62 2.63 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.449 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -103.28 -24.3 13.54 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.652 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -61.78 141.39 95.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.1 Cg_endo -77.59 -18.15 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.55 2.167 . . . . 0.0 110.248 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.72 -2.73 58.34 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.013 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.838 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 p -88.09 -40.18 14.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.012 . . . . 0.0 109.457 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.879 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.38 -30.88 65.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 108.36 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -97.22 -37.63 10.01 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.65 -0.82 . . . . 0.0 112.01 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 23' ' ' VAL . 78.2 m-20 -87.85 -45.67 10.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.941 -1.099 . . . . 0.0 112.656 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -53.75 -50.43 83.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 120.642 -1.286 . . . . 0.0 110.658 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.76 -49.66 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 121.17 1.247 . . . . 0.0 109.754 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.37 -25.85 4.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.705 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.79 -52.11 9.44 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.321 -1.105 . . . . 0.0 108.958 178.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.755 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.5 m -52.13 -37.66 55.02 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.854 -1.154 . . . . 0.0 109.417 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.9 m -66.81 -34.49 77.92 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.189 -0.944 . . . . 0.0 109.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' PHE . 7.2 t80 -69.58 -28.02 65.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.837 . . . . 0.0 111.188 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.637 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 1.6 mtt -95.53 5.82 50.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.671 -1.268 . . . . 0.0 111.779 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.8 OUTLIER 82.95 29.33 0.09 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.353 -0.842 . . . . 0.0 111.255 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.637 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.64 6.8 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.604 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -122.11 145.32 48.28 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.729 -1.232 . . . . 0.0 110.715 -179.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.054 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.9 tp -88.61 101.32 13.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.078 ' CG1' HD23 ' A' ' 76' ' ' LEU . 81.2 t -72.19 -51.36 30.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.827 -1.17 . . . . 0.0 110.43 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -145.77 130.35 17.9 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.167 -1.583 . . . . 0.0 110.779 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.054 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.34 161.5 13.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.875 -2.39 . . . . 0.0 110.786 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CB ' ' HB2' ' A' ' 74' ' ' ARG . 23.5 mm-40 -137.7 111.82 8.47 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -137.85 31.77 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.15 5.33 12.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.532 -0.73 . . . . 0.0 110.05 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.21 127.28 2.89 Favored Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.1 mt -34.23 146.44 0.14 Allowed Pre-proline 0 C--N 1.28 -2.415 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.765 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.4 Cg_endo -81.25 148.51 73.76 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.209 -1.996 . . . . 0.0 108.91 -0.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.879 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.7 m-85 -71.96 164.17 26.57 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 121.426 -0.796 . . . . 0.0 110.265 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.813 ' HG3' HG23 ' A' ' 42' ' ' ILE . 4.1 mtt180 -147.86 152.83 38.28 Favored 'General case' 0 C--O 1.2 -1.513 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.653 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.37 123.07 6.21 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.063 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.078 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.0 tp -88.75 150.07 23.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' SG ' ' A' ' 56' ' ' CYS . 3.9 mt -143.56 109.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 C-N-CA 118.146 -1.421 . . . . 0.0 110.143 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.88 ' H ' HG23 ' A' ' 64' ' ' VAL . 13.2 ttt180 -72.53 114.02 10.2 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.255 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -59.67 106.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.5 166.9 26.34 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.586 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.7 p -94.9 160.4 14.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.325 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -109.74 97.55 7.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.629 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 4.5 mt -80.34 -25.79 39.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.3 m-30 -86.65 16.28 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.609 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 50.6 m -45.73 174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.426 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.93 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.078 -1.013 . . . . 0.0 109.35 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.62 170.07 21.0 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.636 2.224 . . . . 0.0 110.412 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 12.4 m-20 -80.1 -22.62 41.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.054 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.7 m-70 -147.23 174.67 11.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 12' ' ' LEU . 34.5 m -144.99 160.33 41.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.965 -1.084 . . . . 0.0 109.473 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.92 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.9 tp -145.18 108.23 4.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.397 -0.814 . . . . 0.0 109.754 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.626 ' N ' HD12 ' A' ' 12' ' ' LEU . 29.1 t70 -76.24 139.2 41.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.97 18.41 1.78 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 123.809 1.766 . . . . 0.0 107.917 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.012 HD21 HG22 ' A' ' 42' ' ' ILE . 12.7 mt -80.09 106.88 12.44 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.19 -7.55 62.3 Favored Glycine 0 C--N 1.282 -2.463 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -90.39 147.98 23.11 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.7 ptt-85 -142.92 147.93 36.08 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.637 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 t -47.21 141.53 6.2 Favored Pre-proline 0 C--N 1.287 -2.132 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.761 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.0 Cg_endo -89.0 3.29 70.04 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 O-C-N 123.737 1.388 . . . . 0.0 111.572 -0.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 75.2 mt-10 -51.5 -47.89 88.02 Favored Pre-proline 0 N--CA 1.509 2.483 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 21' ' ' GLU . 27.5 Cg_endo -69.69 -61.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.733 1.622 . . . . 0.0 108.028 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.784 HG13 ' CB ' ' A' ' 55' ' ' PHE . 87.5 t -47.12 -25.87 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' PRO . 25.1 mtp -75.14 -42.72 55.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.2 mmt -58.93 -43.78 91.22 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.331 -0.856 . . . . 0.0 109.097 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' CD2' ' A' ' 12' ' ' LEU . 71.4 t -63.79 -29.03 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 32.1 mmm-85 -65.89 -54.09 31.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 8.2 mttm -59.76 -44.69 93.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.812 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.16 -35.96 78.51 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.1 t -69.53 -27.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.7 mtp180 -75.56 -30.57 59.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -103.92 2.64 32.73 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.363 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.563 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.7 mtp -89.69 172.09 9.19 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.168 -0.958 . . . . 0.0 109.449 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.7 mm-40 -135.02 153.9 78.78 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 28.8 Cg_endo -68.48 117.72 5.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.754 1.636 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.0 16.37 10.69 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.4 mm-40 -117.23 -176.91 3.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.456 -1.026 . . . . 0.0 109.318 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -139.98 153.43 46.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.007 -1.058 . . . . 0.0 110.751 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -141.5 117.22 10.37 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.552 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.5 tp -87.38 145.33 26.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -138.66 144.3 30.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 110.848 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.012 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -119.7 158.24 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.14 126.88 2.85 Favored 'General case' 0 C--N 1.281 -2.405 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.366 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.7 p30 -103.27 -23.87 13.57 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -60.16 142.73 89.47 Favored Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.2 Cg_endo -77.77 -19.0 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.409 2.073 . . . . 0.0 110.389 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.27 -2.22 58.0 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.684 -0.635 . . . . 0.0 110.231 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.771 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.1 p -86.09 -41.76 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.016 . . . . 0.0 109.778 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.877 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.08 -30.34 61.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.987 -1.07 . . . . 0.0 108.63 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -97.07 -37.04 10.3 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.017 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.783 ' HB3' HG21 ' A' ' 23' ' ' VAL . 84.3 m-20 -89.31 -45.31 9.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.055 -1.028 . . . . 0.0 112.81 -176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.4 mt -54.86 -51.22 81.06 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.734 -1.229 . . . . 0.0 110.734 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.14 -49.92 0.21 Allowed 'Trans proline' 0 C--N 1.298 -2.131 0 C-N-CA 121.275 1.316 . . . . 0.0 109.72 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.52 -24.74 5.78 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.784 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.31 -52.1 9.75 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.346 -1.091 . . . . 0.0 109.008 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.797 ' SG ' HG21 ' A' ' 77' ' ' ILE . 10.8 m -53.92 -40.31 66.62 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.895 -1.128 . . . . 0.0 109.518 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.3 m -62.73 -33.13 74.5 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.136 -0.978 . . . . 0.0 109.44 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -70.11 -32.3 70.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.375 -0.828 . . . . 0.0 110.961 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.623 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 11.8 mmt -90.07 6.22 43.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.706 -1.246 . . . . 0.0 111.315 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.1 OUTLIER 81.29 28.09 0.18 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.197 -0.94 . . . . 0.0 111.045 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -95.63 174.76 6.82 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 108.252 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 5.2 mt-10 -120.04 138.46 53.51 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.79 -1.194 . . . . 0.0 111.107 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.076 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.0 tp -82.65 100.34 10.13 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 84.2 t -71.32 -50.12 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.858 -1.151 . . . . 0.0 110.649 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.51 130.25 17.05 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.183 -1.573 . . . . 0.0 110.719 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.076 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.1 161.19 13.76 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 118.853 -2.404 . . . . 0.0 110.742 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 7.6 mm-40 -138.66 111.62 7.84 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.174 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -138.6 30.86 2.32 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -78.56 5.37 11.06 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.647 0.737 . . . . 0.0 110.006 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.07 126.03 2.7 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.4 mt -34.57 147.02 0.14 Allowed Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.794 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.36 148.76 73.62 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.159 -2.017 . . . . 0.0 108.881 -0.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.877 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.4 m-85 -72.53 163.63 27.73 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.47 -0.769 . . . . 0.0 110.281 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 3.0 mtp180 -147.57 151.99 37.21 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.731 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.23 124.03 7.32 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.155 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.7 tp -89.08 150.37 22.77 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.797 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.8 mt -143.61 108.13 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.253 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.908 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.7 ttt180 -72.36 110.6 6.89 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.019 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 13.6 tmtt? -59.69 133.48 56.13 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.523 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . 179.91 -172.27 43.84 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.534 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.6 m -77.21 123.63 26.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.38 137.61 42.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 24.1 mt -83.31 -8.1 59.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.481 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.081 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.24 16.25 4.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 5' ' ' PHE . 44.0 m -46.08 174.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.061 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' SER . 14.9 p -46.53 104.3 0.4 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.837 -1.165 . . . . 0.0 109.057 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 34.5 Cg_endo -74.9 164.83 32.67 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.541 2.16 . . . . 0.0 110.382 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 78.8 m-20 -79.21 -23.78 43.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' CB ' HD12 ' A' ' 39' ' ' LEU . 18.8 m-70 -144.42 174.49 10.88 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.8 m -145.73 161.66 39.4 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.125 -0.984 . . . . 0.0 109.439 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.989 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.7 tp -148.19 108.2 4.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 109.829 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 12' ' ' LEU . 35.1 t70 -74.72 137.86 42.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -142.44 18.91 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 123.882 1.801 . . . . 0.0 107.996 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.888 HD21 HG22 ' A' ' 42' ' ' ILE . 2.5 mt -81.66 105.71 13.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 99.83 -4.03 57.57 Favored Glycine 0 C--N 1.282 -2.461 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.91 148.27 22.49 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.15 147.25 34.63 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.489 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.7 t -47.18 141.59 6.08 Favored Pre-proline 0 C--N 1.286 -2.155 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.709 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.3 Cg_endo -88.68 3.53 69.88 Favored 'Cis proline' 0 C--N 1.307 -1.633 0 O-C-N 123.647 1.341 . . . . 0.0 111.637 -0.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 87.5 mt-10 -51.96 -47.53 90.91 Favored Pre-proline 0 N--CA 1.509 2.511 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.746 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.5 Cg_endo -70.29 -60.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.292 -2.436 0 N-CA-C 107.988 -1.581 . . . . 0.0 107.988 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.82 HG22 ' HA ' ' A' ' 52' ' ' ILE . 75.3 t -46.95 -26.43 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -75.04 -42.55 56.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.78 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.711 ' HB3' HD13 ' A' ' 12' ' ' LEU . 15.9 mmt -60.0 -43.68 95.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.188 -0.945 . . . . 0.0 109.009 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.849 HG23 HD23 ' A' ' 12' ' ' LEU . 72.0 t -63.34 -27.41 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 108.606 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 mmm180 -66.97 -56.48 9.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.406 -0.809 . . . . 0.0 109.774 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -60.46 -39.05 86.18 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.9 -35.13 79.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -68.53 -28.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.1 mtp180 -76.58 -30.45 57.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.3 p30 -101.87 9.2 40.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.527 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.566 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.3 mtp -98.11 -177.87 3.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.68 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 6.2 mt-30 -138.35 153.78 73.15 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.65 121.73 8.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.887 1.725 . . . . 0.0 109.763 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.2 16.52 20.67 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 6.8 mt-10 -114.45 -175.6 2.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.496 -1.003 . . . . 0.0 108.973 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.51 ' HB ' HD11 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -137.62 156.82 47.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.491 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.852 HD23 HD11 ' A' ' 41' ' ' ILE . 3.8 tp -144.72 118.48 9.25 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 27.5 tp -86.92 145.57 26.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.989 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -142.4 125.64 14.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.06 -1.025 . . . . 0.0 110.797 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.904 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 2.2 mt -100.42 163.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.839 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.51 127.13 2.74 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.232 -0.987 . . . . 0.0 108.9 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 8.8 p30 -104.35 -24.34 13.1 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.9 OUTLIER -61.81 141.94 95.03 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.6 Cg_endo -77.26 -18.36 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.414 2.076 . . . . 0.0 110.374 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' A' ' 51' ' ' ASP . . . -90.84 -2.95 57.72 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.669 -0.645 . . . . 0.0 110.024 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.839 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 6.1 p -85.99 -42.62 13.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.884 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.4 -32.67 57.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 108.707 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -96.48 -38.08 10.16 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.144 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.558 ' HB3' HG21 ' A' ' 23' ' ' VAL . 2.2 m-20 -84.52 -47.79 10.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.042 -1.036 . . . . 0.0 112.629 -177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.82 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.73 -48.49 87.2 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.742 -1.224 . . . . 0.0 111.238 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.99 -50.19 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.22 1.28 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.72 -25.42 4.8 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 107.991 -2.043 . . . . 0.0 107.991 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.8 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.02 -53.12 8.22 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.386 -1.067 . . . . 0.0 108.893 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 26' ' ' VAL . 50.7 m -54.0 -37.41 64.0 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.928 -1.107 . . . . 0.0 109.921 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.4 m -65.48 -34.43 78.26 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.75 -32.51 71.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.461 -0.774 . . . . 0.0 110.888 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.615 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -87.27 5.61 37.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.876 -1.14 . . . . 0.0 111.594 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.4 OUTLIER 83.19 22.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.296 -0.877 . . . . 0.0 110.788 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.15 174.37 6.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.206 -0.934 . . . . 0.0 108.5 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 6.3 mt-10 -123.54 144.45 49.56 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.75 -1.219 . . . . 0.0 111.662 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.092 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.7 tp -85.32 102.59 13.51 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.099 ' CG1' HD23 ' A' ' 76' ' ' LEU . 79.5 t -71.17 -49.03 51.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.762 -1.211 . . . . 0.0 110.587 -176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 129.85 15.78 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.155 -1.59 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.092 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.39 156.72 16.61 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 118.95 -2.344 . . . . 0.0 110.783 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -131.4 112.03 12.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.972 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.1 p -138.31 32.44 2.34 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -80.25 5.98 13.15 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.588 0.709 . . . . 0.0 109.953 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.2 127.65 2.93 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.0 mt -36.76 147.08 0.21 Allowed Pre-proline 0 C--N 1.281 -2.408 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.622 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -80.93 147.74 74.14 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.257 -1.976 . . . . 0.0 108.921 -0.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.884 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -71.61 166.09 22.58 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 121.534 -0.729 . . . . 0.0 110.33 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG3' HG23 ' A' ' 42' ' ' ILE . 1.5 mtm105 -148.37 154.05 39.42 Favored 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -154.65 124.53 6.66 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.976 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.099 HD23 ' CG1' ' A' ' 64' ' ' VAL . 21.0 tp -88.54 152.42 21.87 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.727 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.11 108.9 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 C-N-CA 118.196 -1.402 . . . . 0.0 110.158 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.884 ' H ' HG23 ' A' ' 64' ' ' VAL . 7.7 ttm-85 -71.51 110.1 5.88 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.584 -1.246 . . . . 0.0 108.141 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.668 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -69.73 110.82 5.11 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.31 160.11 13.09 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.547 179.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 t -55.26 160.68 2.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.428 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.09 118.79 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 50.3 mt -89.75 -0.99 57.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 109.518 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.044 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.32 16.51 3.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.875 . . . . 0.0 109.914 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.5 m -44.87 174.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.481 -0.762 . . . . 0.0 109.514 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.9 p -46.69 104.24 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 0.0 109.265 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.9 Cg_endo -75.32 175.03 11.8 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.633 2.222 . . . . 0.0 110.291 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 37' ' ' GLU . 21.0 m-20 -87.85 -23.37 24.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.593 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.0 m-70 -144.11 174.27 11.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.258 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 12' ' ' LEU . 30.7 m -145.35 159.83 42.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.864 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.88 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.7 tp -148.43 113.27 5.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.403 -0.811 . . . . 0.0 109.977 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' N ' HD12 ' A' ' 12' ' ' LEU . 12.8 t70 -81.95 140.47 34.0 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.76 20.34 1.82 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 123.897 1.808 . . . . 0.0 108.121 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mt -83.81 105.45 14.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.11 -0.68 54.6 Favored Glycine 0 C--N 1.282 -2.417 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.571 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.2 mt -98.38 149.9 22.17 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 2.6 ptt180 -143.16 147.49 35.01 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 117.886 -1.526 . . . . 0.0 109.464 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.22 141.57 6.18 Favored Pre-proline 0 C--N 1.287 -2.15 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.742 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.64 3.58 69.86 Favored 'Cis proline' 0 C--N 1.307 -1.612 0 O-C-N 123.673 1.354 . . . . 0.0 111.709 -0.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 35.3 mt-10 -52.88 -47.15 96.2 Favored Pre-proline 0 N--CA 1.508 2.459 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.6 Cg_endo -69.32 -63.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 121.73 1.62 . . . . 0.0 108.052 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 52' ' ' ILE . 73.9 t -47.14 -25.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 40.6 mtp -74.34 -43.08 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.456 -0.778 . . . . 0.0 109.916 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.721 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -59.03 -43.32 91.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 0.0 108.747 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.864 HG23 ' CD2' ' A' ' 12' ' ' LEU . 78.9 t -65.01 -26.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.19 -61.14 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -61.07 -37.46 82.76 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.601 0.715 . . . . 0.0 109.293 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.68 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -67.22 -34.13 76.83 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.4 t -69.45 -29.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 10.0 mtp-105 -73.81 -30.69 62.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 32.9 p30 -101.0 9.01 42.73 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.474 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 mtp -100.42 178.98 4.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -138.5 152.99 72.19 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.8 Cg_endo -70.47 120.79 7.4 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 121.82 1.68 . . . . 0.0 109.927 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.39 9.19 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -121.26 -175.35 3.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.538 -0.978 . . . . 0.0 109.383 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -137.02 157.07 47.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 110.657 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 41' ' ' ILE . 3.9 tp -143.49 117.01 9.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.2 tp -87.79 141.49 28.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -137.22 152.87 28.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.229 -0.919 . . . . 0.0 110.482 -178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.926 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -127.41 162.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.82 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.41 129.22 2.71 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.809 -1.156 . . . . 0.0 109.423 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 12.0 p30 -104.62 -24.43 12.97 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.59 141.25 94.88 Favored Pre-proline 0 C--N 1.309 -1.192 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -17.91 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.517 2.145 . . . . 0.0 110.38 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.84 -2.97 57.72 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.715 -0.616 . . . . 0.0 110.114 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.82 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 p -87.55 -39.08 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.504 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.72 -31.53 66.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.965 -1.084 . . . . 0.0 108.388 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -96.56 -36.69 10.66 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.984 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 3.1 m-20 -89.54 -45.44 9.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.939 -1.1 . . . . 0.0 112.594 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.5 mt -53.17 -50.8 80.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.761 -1.212 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -50.24 0.24 Allowed 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.259 1.306 . . . . 0.0 109.823 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.25 -24.68 5.16 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.719 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.57 -54.4 6.74 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.328 -1.101 . . . . 0.0 108.878 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.855 ' SG ' HG11 ' A' ' 26' ' ' VAL . 24.1 m -54.65 -36.84 64.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.91 -1.119 . . . . 0.0 110.222 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -68.33 -31.85 71.56 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.021 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.22 -29.04 60.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 111.363 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.596 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 8.5 mmt -88.45 4.31 46.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.631 -1.293 . . . . 0.0 111.483 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.581 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 88.57 22.18 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.644 -0.66 . . . . 0.0 110.358 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.4 m-70 -96.14 173.83 7.21 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 16.7 mt-10 -123.35 141.58 51.84 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.665 -1.272 . . . . 0.0 111.391 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.021 HD21 ' CG ' ' A' ' 66' ' ' LYS . 4.0 tp -84.25 101.62 12.04 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.08 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.9 t -72.14 -49.61 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.842 -1.162 . . . . 0.0 110.74 -176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.044 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.83 130.27 16.75 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.192 -1.568 . . . . 0.0 110.718 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.021 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.93 161.7 13.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 118.966 -2.334 . . . . 0.0 110.579 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -139.09 112.07 7.93 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.767 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -136.62 32.42 2.76 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.95 5.0 12.65 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.644 0.735 . . . . 0.0 110.008 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.26 126.5 2.74 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -35.29 146.94 0.16 Allowed Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.871 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.39 147.82 71.78 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.227 -1.989 . . . . 0.0 108.812 -1.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.3 m-85 -70.47 163.05 27.6 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.492 -0.755 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.8 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.3 mtt180 -145.47 152.03 39.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.676 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.2 m-85 -151.93 123.54 7.89 Favored 'General case' 0 C--N 1.276 -2.587 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.036 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.08 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.8 tp -88.51 150.84 22.89 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.715 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.67 109.7 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.201 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.895 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.8 ttt85 -71.29 107.92 4.51 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.903 -1.119 . . . . 0.0 108.542 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 6.3 tmtt? -57.61 132.49 53.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' N ' ' HD3' ' A' ' 79' ' ' LYS . . . -138.6 -172.32 12.51 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA3' ' CD ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 117.898 -1.501 . . . . 0.0 109.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 t -61.89 159.43 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.69 154.97 36.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.512 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 20.6 mt -98.71 -40.41 8.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.101 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.51 16.01 4.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.162 -0.961 . . . . 0.0 109.751 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 5' ' ' PHE . 70.8 m -46.61 174.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 108.983 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.4 p -47.47 104.36 0.41 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.02 -1.05 . . . . 0.0 109.014 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.5 Cg_endo -75.32 167.58 26.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.445 2.097 . . . . 0.0 110.354 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -23.56 34.91 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.134 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.567 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.8 m-70 -142.57 171.06 14.57 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.352 -0.842 . . . . 0.0 109.291 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.5 m -145.23 161.35 39.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.115 -0.991 . . . . 0.0 109.365 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.945 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -145.15 107.42 4.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 12' ' ' LEU . 26.5 t70 -74.66 136.98 41.89 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -141.91 17.34 2.13 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 123.733 1.73 . . . . 0.0 107.833 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 42' ' ' ILE . 15.5 mt -79.13 106.93 11.51 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.48 -5.68 62.7 Favored Glycine 0 C--N 1.284 -2.317 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 3.7 mt -91.86 147.87 22.65 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -143.28 150.11 38.8 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 117.765 -1.574 . . . . 0.0 109.609 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 7.6 t -47.08 141.68 5.79 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 119.219 -0.993 . . . . 0.0 108.701 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 45.0 Cg_endo -88.72 3.47 69.9 Favored 'Cis proline' 0 C--N 1.306 -1.662 0 O-C-N 123.676 1.356 . . . . 0.0 111.547 -0.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt-10 -52.5 -47.09 94.69 Favored Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -176.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.712 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.3 Cg_endo -69.22 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.294 -2.293 0 C-N-CA 121.851 1.7 . . . . 0.0 108.59 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 55' ' ' PHE . 57.8 t -48.13 -25.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -75.19 -40.57 59.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.885 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.733 ' HB3' HD13 ' A' ' 12' ' ' LEU . 4.3 mmt -62.95 -43.14 99.6 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.259 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.848 HG23 HD23 ' A' ' 12' ' ' LEU . 73.9 t -63.39 -28.01 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 108.532 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 1.6 mmm180 -66.21 -57.26 7.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.446 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -59.72 -39.92 86.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.778 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.95 -35.25 80.08 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.3 t -68.52 -29.0 42.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 58.5 mtp180 -76.69 -30.45 56.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -101.01 7.31 43.54 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.383 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.559 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.6 mtp -96.36 169.37 9.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.954 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 22.4 mt-30 -127.88 152.98 78.07 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.3 Cg_endo -71.05 123.28 9.53 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.804 1.669 . . . . 0.0 109.49 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.02 10.15 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 106.964 -2.454 . . . . 0.0 106.964 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 2.4 mp0 -120.87 -175.61 3.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.549 -0.971 . . . . 0.0 109.715 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.662 HG23 ' HG2' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.04 157.24 47.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.347 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 HG21 ' A' ' 29' ' ' THR . 3.8 tp -144.13 116.46 8.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 19.9 tp -87.87 141.45 28.58 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.945 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.6 mt -135.12 137.54 50.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.992 -1.067 . . . . 0.0 110.62 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.8 mt -113.08 155.59 14.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.775 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.37 3.3 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.56 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.2 p30 -101.96 -24.65 13.97 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 105.115 -2.179 . . . . 0.0 105.115 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.803 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -60.67 141.47 92.36 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -78.02 -19.36 12.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.51 2.14 . . . . 0.0 110.467 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -87.23 -2.91 58.97 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.044 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' OD2' ' A' ' 45' ' ' ASP . 9.0 p -88.29 -40.63 13.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 109.485 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -57.19 -31.74 65.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 108.523 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -97.13 -37.49 10.1 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.879 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB3' HG21 ' A' ' 23' ' ' VAL . 60.9 m-20 -88.12 -45.67 9.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.959 -1.088 . . . . 0.0 112.802 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 23' ' ' VAL . 2.1 mt -54.18 -52.15 71.25 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 120.695 -1.253 . . . . 0.0 110.773 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.7 Cg_endo -71.58 -50.01 0.31 Allowed 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 121.226 1.284 . . . . 0.0 109.831 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.31 -24.9 5.47 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.981 -2.048 . . . . 0.0 107.981 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.744 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -75.95 -53.42 8.43 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.437 -1.037 . . . . 0.0 109.024 178.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.796 ' SG ' HG11 ' A' ' 26' ' ' VAL . 47.5 m -57.85 -39.05 76.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.878 -1.139 . . . . 0.0 110.526 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 27.3 m -65.37 -33.78 76.77 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.898 -1.126 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -78.05 -21.88 49.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.888 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -97.07 14.7 24.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.655 -1.278 . . . . 0.0 111.286 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' MET . 1.3 mm-40 74.89 29.3 1.03 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.642 -0.661 . . . . 0.0 111.43 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.74 174.34 6.86 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 9.2 mm-40 -119.93 136.79 54.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.593 -1.317 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.922 HD21 ' CG ' ' A' ' 66' ' ' LYS . 6.1 tp -85.42 101.35 12.53 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.09 ' CG1' HD23 ' A' ' 76' ' ' LEU . 76.3 t -73.52 -51.77 23.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.775 -1.203 . . . . 0.0 110.55 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.101 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.24 130.42 17.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.077 -1.64 . . . . 0.0 110.918 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.922 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.84 160.39 14.34 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 118.849 -2.407 . . . . 0.0 110.66 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.28 111.75 8.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.397 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 p -138.22 32.83 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.01 5.25 12.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.572 0.701 . . . . 0.0 109.961 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 130.7 127.91 2.93 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.789 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.3 mt -35.53 145.99 0.2 Allowed Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 115.117 -0.541 . . . . 0.0 110.733 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 Cg_endo -81.69 148.72 71.9 Favored 'Cis proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.109 -2.038 . . . . 0.0 109.037 -0.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.8 m-85 -73.86 164.99 25.91 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.553 -0.717 . . . . 0.0 110.227 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 22.2 mtm180 -148.55 152.19 36.39 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.703 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.53 123.06 6.69 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.918 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.09 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.5 tp -89.2 151.81 21.95 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -143.7 111.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 118.201 -1.4 . . . . 0.0 110.14 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.861 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -70.98 109.71 5.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.933 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.0 tptm -56.62 129.57 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.01 -172.62 36.68 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.311 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.294 0.568 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.33 160.47 15.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.69 97.23 11.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.513 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 22.1 mt -98.86 -11.75 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.073 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.5 m-30 -86.53 16.1 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.392 -0.818 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -45.63 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.403 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -46.92 103.51 0.36 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.058 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 36.1 Cg_endo -75.56 168.05 25.24 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.516 2.144 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 1.2 m-20 -80.2 -22.88 41.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -0.881 . . . . 0.0 109.06 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 16.1 m-70 -146.75 175.37 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.413 -0.805 . . . . 0.0 109.619 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 12' ' ' LEU . 39.9 m -145.62 161.58 39.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 3.5 tp -146.96 111.48 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.832 . . . . 0.0 109.636 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.632 ' N ' HD12 ' A' ' 12' ' ' LEU . 8.6 t70 -79.91 140.61 36.64 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -145.62 19.53 1.5 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 123.992 1.853 . . . . 0.0 108.023 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 HG22 ' A' ' 42' ' ' ILE . 15.7 mt -77.15 110.94 12.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 91.61 -5.74 80.05 Favored Glycine 0 C--N 1.285 -2.299 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -90.62 147.44 23.31 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.8 ptt85 -142.84 148.12 36.54 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 117.584 -1.646 . . . . 0.0 109.654 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -46.78 141.53 5.41 Favored Pre-proline 0 C--N 1.289 -2.054 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.728 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.51 3.45 69.79 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.663 1.349 . . . . 0.0 111.724 -0.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -53.35 -47.73 95.11 Favored Pre-proline 0 N--CA 1.51 2.546 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.704 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.8 Cg_endo -70.38 -63.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.403 0 C-N-CA 121.981 1.787 . . . . 0.0 107.85 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CB ' ' A' ' 55' ' ' PHE . 75.0 t -47.3 -25.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 12.6 mtp -74.08 -43.18 58.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 0.0 109.756 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.706 ' HB3' HD13 ' A' ' 12' ' ' LEU . 42.0 mmm -60.32 -43.24 96.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.181 -0.949 . . . . 0.0 109.172 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 79.3 t -62.68 -28.68 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.023 . . . . 0.0 108.814 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 1.2 mmm180 -64.92 -55.31 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.168 -0.958 . . . . 0.0 109.675 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 11.5 mmmm -60.22 -45.43 93.25 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.76 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -62.18 -34.59 76.72 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.4 t -69.5 -28.97 39.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 5.9 mtp85 -76.19 -29.51 57.68 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 36.8 p30 -101.76 1.68 37.6 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.563 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 7.4 mtp -87.58 169.01 12.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 44.8 mt-30 -128.11 154.37 78.63 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.4 Cg_endo -69.22 123.33 10.17 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.622 1.548 . . . . 0.0 109.826 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 20.24 14.86 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mp0 -117.17 -174.93 2.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.472 -1.017 . . . . 0.0 109.688 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -140.05 152.9 46.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.744 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.76 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -143.74 116.03 8.5 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 10.7 tp -87.66 144.36 26.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.848 -1.158 . . . . 0.0 108.256 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.795 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.0 mt -135.52 151.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.723 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.084 HG22 HD21 ' A' ' 15' ' ' LEU . 1.5 mt -126.43 158.54 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.8 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.72 129.75 3.61 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.592 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.564 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -104.2 -27.58 11.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -59.61 142.52 87.54 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.6 Cg_endo -77.98 -19.85 12.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.413 2.075 . . . . 0.0 110.282 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.52 -2.66 58.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.106 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.8 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 1.9 p -87.73 -40.32 14.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.061 -1.025 . . . . 0.0 109.415 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.881 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.84 -31.24 64.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -96.71 -38.1 10.05 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.037 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.57 -45.25 10.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.976 -1.077 . . . . 0.0 112.616 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.764 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -53.63 -50.63 82.28 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.772 -1.205 . . . . 0.0 110.827 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.9 Cg_endo -73.0 -50.1 0.21 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.249 1.3 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.22 -25.04 5.39 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.771 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.29 -53.15 8.05 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.344 -1.092 . . . . 0.0 108.897 178.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.807 ' SG ' HG11 ' A' ' 26' ' ' VAL . 33.9 m -53.28 -37.28 62.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.929 -1.107 . . . . 0.0 109.794 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.21 -33.03 74.84 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.119 -0.988 . . . . 0.0 110.041 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.45 -31.16 65.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.373 -0.829 . . . . 0.0 111.363 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.626 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.2 mtp -90.44 7.1 40.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.637 -1.289 . . . . 0.0 111.75 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.2 OUTLIER 83.94 26.09 0.1 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.26 -0.9 . . . . 0.0 111.06 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.626 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.92 173.84 7.09 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 12.4 mm-40 -123.13 140.85 52.6 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.072 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.3 tp -85.47 102.05 13.16 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.11 ' CG1' HD23 ' A' ' 76' ' ' LEU . 71.3 t -71.46 -49.6 46.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.873 -1.142 . . . . 0.0 110.949 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.073 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 128.69 14.82 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.031 -1.668 . . . . 0.0 111.249 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.072 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.55 156.89 17.04 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.257 -2.152 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.615 ' OE1' ' CZ ' ' A' ' 5' ' ' PHE . 1.3 mp0 -139.9 111.9 7.52 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.941 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 p -135.38 33.71 3.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.15 4.83 11.51 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.564 0.697 . . . . 0.0 110.087 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 135.85 125.92 2.53 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD21 ' CE2' ' A' ' 73' ' ' TYR . 9.1 mt -36.82 147.79 0.2 Allowed Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.763 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.6 Cg_endo -81.63 147.28 69.34 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.182 -2.008 . . . . 0.0 108.927 -1.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CD2' HG22 ' A' ' 49' ' ' THR . 5.4 m-85 -70.79 165.6 22.78 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.555 -0.716 . . . . 0.0 110.258 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.64 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -149.12 151.25 34.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.729 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.8 OUTLIER -153.75 126.33 8.13 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 119.223 -0.991 . . . . 0.0 108.957 -178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.11 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.3 tp -89.32 152.88 21.3 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.45 107.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.473 -1.291 . . . . 0.0 109.903 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.901 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.2 ttp85 -72.97 117.82 15.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.082 -1.011 . . . . 0.0 109.157 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.65 106.19 0.93 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.27 167.68 27.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.445 179.757 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -52.75 160.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.58 107.34 19.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.663 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 39.2 mt -93.31 -9.29 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.018 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -85.83 16.37 4.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.762 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' PHE . 7.1 t -45.11 174.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.442 -0.786 . . . . 0.0 109.659 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 51.9 p -47.14 103.69 0.37 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.269 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 36.2 Cg_endo -75.76 172.28 16.59 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.725 2.283 . . . . 0.0 110.438 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 66.3 m-20 -80.37 -23.97 40.11 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.232 -0.917 . . . . 0.0 108.809 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CB ' HD12 ' A' ' 39' ' ' LEU . 12.4 m-70 -144.96 174.84 10.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' LEU . 44.3 m -145.01 160.99 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.965 -1.085 . . . . 0.0 109.72 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.972 ' HB3' HG23 ' A' ' 41' ' ' ILE . 5.8 tp -148.96 128.52 13.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.013 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.79 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.4 t70 -97.81 138.15 35.61 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -143.14 21.27 1.92 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.971 1.843 . . . . 0.0 107.985 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -83.6 105.22 14.35 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 113.199 -1.819 . . . . 0.0 106.12 176.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 101.63 0.59 52.87 Favored Glycine 0 C--N 1.282 -2.444 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 6.2 mt -99.39 151.34 21.2 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.43 147.83 35.21 Favored 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.594 178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.7 141.7 7.23 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.602 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.71 3.63 69.9 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 O-C-N 123.668 1.351 . . . . 0.0 111.551 -0.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.8 mt-10 -52.17 -47.18 92.9 Favored Pre-proline 0 N--CA 1.509 2.499 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.729 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.5 Cg_endo -69.07 -62.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.31 0 C-N-CA 121.682 1.588 . . . . 0.0 108.318 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 52' ' ' ILE . 58.8 t -49.06 -25.59 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 2.1 mmt -74.55 -39.44 62.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 109.874 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -53.02 61.94 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.216 -0.927 . . . . 0.0 108.633 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.819 HG11 ' SG ' ' A' ' 56' ' ' CYS . 78.6 t -54.92 -27.67 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.9 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -63.88 -57.7 9.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -59.1 -45.94 89.58 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.35 -34.68 75.7 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 t -69.25 -29.61 43.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 16.7 mtp-105 -75.05 -29.44 60.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 37.1 p30 -103.81 5.6 36.09 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.585 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 mtp -93.6 179.6 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.942 . . . . 0.0 109.783 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 7.7 mt-30 -134.64 153.7 79.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.0 Cg_endo -69.69 121.82 8.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.881 1.721 . . . . 0.0 109.864 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' NH2' ' A' ' 78' ' ' ARG . . . 103.75 16.82 18.56 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 15.6 mt-10 -114.85 -175.98 2.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.462 -1.022 . . . . 0.0 109.047 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -137.2 155.96 48.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.983 -1.073 . . . . 0.0 110.501 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD13 HG21 ' A' ' 29' ' ' THR . 3.5 tp -145.16 116.48 7.98 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 21.6 tp -86.87 147.09 25.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.924 -1.11 . . . . 0.0 108.018 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.972 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -141.46 156.31 21.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.158 -0.963 . . . . 0.0 110.8 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.932 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -130.49 163.59 35.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.85 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.36 128.62 2.63 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.16 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.8 p30 -103.59 -25.14 13.3 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.601 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -62.05 141.58 95.68 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.5 Cg_endo -77.24 -18.77 13.97 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.501 2.134 . . . . 0.0 110.408 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -89.31 -2.77 58.58 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.111 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.85 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.3 p -87.38 -41.18 13.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.391 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.862 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.17 -32.09 64.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 108.478 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -96.37 -37.73 10.35 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.977 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB3' HG21 ' A' ' 23' ' ' VAL . 81.6 m-20 -87.41 -46.91 9.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.95 -1.094 . . . . 0.0 112.513 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.911 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.68 -49.88 80.52 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 111.163 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.0 Cg_endo -72.11 -50.11 0.27 Allowed 'Trans proline' 0 C--N 1.297 -2.139 0 C-N-CA 121.109 1.206 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -24.98 4.7 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.49 -54.89 6.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.376 -1.073 . . . . 0.0 108.79 178.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.819 ' SG ' HG11 ' A' ' 26' ' ' VAL . 38.4 m -53.2 -37.36 61.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.878 -1.139 . . . . 0.0 109.857 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -67.19 -33.13 74.73 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.752 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -71.61 -29.11 64.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 111.211 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.1 mtt -91.41 5.54 48.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.675 -1.265 . . . . 0.0 111.5 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.6 OUTLIER 85.49 22.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.591 -0.693 . . . . 0.0 110.547 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.5 m-70 -96.3 174.24 6.98 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.6 mt-10 -123.64 143.78 50.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.757 -1.214 . . . . 0.0 111.479 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.083 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.8 tp -86.31 102.36 13.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.074 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.2 t -71.9 -48.24 51.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.78 -1.2 . . . . 0.0 110.927 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.018 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.0 129.84 16.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.13 -1.606 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.083 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.86 161.61 13.54 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 118.993 -2.317 . . . . 0.0 110.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 1.6 mm-40 -138.94 111.76 7.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.376 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.2 p -137.05 32.38 2.65 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 3.7 m-20 -80.09 5.91 12.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 110.064 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.58 126.71 2.74 Favored Glycine 0 C--N 1.292 -1.916 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.5 mt -36.17 147.25 0.19 Allowed Pre-proline 0 C--N 1.282 -2.353 0 CA-C-N 115.081 -0.559 . . . . 0.0 110.687 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.23 147.61 72.37 Favored 'Cis proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.145 -2.023 . . . . 0.0 108.877 -0.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.862 ' CD2' HG22 ' A' ' 49' ' ' THR . 8.0 m-85 -71.01 161.1 31.71 Favored 'General case' 0 C--N 1.286 -2.163 0 O-C-N 121.523 -0.735 . . . . 0.0 109.869 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.922 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.1 mtt180 -145.17 152.26 39.74 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.3 m-85 -151.31 125.05 9.06 Favored 'General case' 0 C--N 1.277 -2.568 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.145 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.074 HD23 ' CG1' ' A' ' 64' ' ' VAL . 18.0 tp -88.4 151.67 22.43 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.7 mt -144.36 109.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 C-N-CA 118.06 -1.456 . . . . 0.0 110.406 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.907 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.77 110.58 6.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.835 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -70.19 109.06 4.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.39 162.65 18.38 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.456 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 p -111.52 110.68 21.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 6' ' ' SER . 2.8 m-20 -112.99 155.95 23.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.703 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 11.7 mt -97.51 -56.89 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.926 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -85.82 15.5 4.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 3' ' ' ASP . 7.8 t -47.12 175.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.268 -0.895 . . . . 0.0 109.048 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.403 ' N ' ' OG ' ' A' ' 6' ' ' SER . 4.4 p -46.76 103.84 0.38 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 109.051 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 34.4 Cg_endo -75.36 165.24 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.48 2.12 . . . . 0.0 110.402 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -73.05 -23.53 60.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 108.828 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CB ' HD12 ' A' ' 39' ' ' LEU . 44.3 m-70 -146.29 173.49 12.2 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.436 -0.79 . . . . 0.0 109.557 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 12' ' ' LEU . 29.3 m -145.78 160.68 41.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.109 -0.994 . . . . 0.0 109.722 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.986 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -147.13 108.91 4.37 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.915 . . . . 0.0 109.872 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.666 ' N ' HD12 ' A' ' 12' ' ' LEU . 31.9 t70 -75.55 134.95 40.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.928 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -139.75 17.76 2.5 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 123.86 1.79 . . . . 0.0 107.993 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 42' ' ' ILE . 3.4 mt -82.07 105.28 13.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 100.43 -1.48 55.89 Favored Glycine 0 C--N 1.281 -2.505 0 N-CA-C 106.894 -2.483 . . . . 0.0 106.894 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' CG ' ' HA ' ' A' ' 14' ' ' ALA . 5.1 mt -97.12 150.05 21.29 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.3 ptp85 -143.05 146.85 34.21 Favored 'General case' 0 C--N 1.278 -2.535 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.404 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.5 t -47.2 141.51 6.19 Favored Pre-proline 0 C--N 1.288 -2.081 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.71 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' PRO . 46.0 Cg_endo -88.79 3.82 69.95 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 O-C-N 123.681 1.359 . . . . 0.0 111.631 -0.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.5 mm-40 -52.91 -46.59 97.11 Favored Pre-proline 0 N--CA 1.509 2.484 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.702 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.6 Cg_endo -69.0 -64.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.407 0 N-CA-C 108.191 -1.504 . . . . 0.0 108.191 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.953 HG22 ' HA ' ' A' ' 52' ' ' ILE . 77.0 t -47.15 -27.0 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 4.5 mtt -70.33 -44.78 67.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.682 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.2 mmt -59.99 -42.49 94.34 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.371 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.878 HG22 HD13 ' A' ' 41' ' ' ILE . 87.4 t -63.25 -27.77 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.065 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.642 ' HD2' ' CE2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.44 -56.13 12.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.184 -0.947 . . . . 0.0 109.72 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 9.6 mttm -61.38 -39.38 90.45 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.665 ' CG2' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.91 -33.58 76.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 t -72.09 -26.64 25.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 6.4 mtt85 -75.2 -32.47 61.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -102.4 9.79 39.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.277 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.576 ' CE ' ' CB ' ' A' ' 79' ' ' LYS . 6.7 mtp -95.69 175.9 6.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.774 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 24.4 mt-30 -138.84 153.77 72.26 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.2 Cg_endo -70.08 122.75 9.34 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.891 1.727 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.57 18.7 10.57 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 107.214 -2.354 . . . . 0.0 107.214 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 12.1 mt-10 -121.56 -175.47 3.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.576 -0.956 . . . . 0.0 109.53 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 p -138.77 153.94 48.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.834 HD23 HD11 ' A' ' 41' ' ' ILE . 3.7 tp -143.92 117.5 9.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 23.8 tp -87.37 146.44 25.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.785 -1.197 . . . . 0.0 107.905 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.986 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.8 mt -142.41 122.53 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 110.606 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.928 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 mt -98.94 163.66 2.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.45 126.91 2.73 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 119.386 -0.925 . . . . 0.0 108.894 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 11.5 p30 -102.66 -24.27 13.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -61.53 142.23 94.26 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.4 Cg_endo -77.49 -18.49 13.77 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.531 2.154 . . . . 0.0 110.393 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -90.0 -2.86 58.21 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.762 -0.586 . . . . 0.0 110.18 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.848 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.0 p -87.47 -39.93 14.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.036 . . . . 0.0 109.416 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.889 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -56.88 -32.11 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.077 -1.015 . . . . 0.0 108.543 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.61 -37.45 10.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.967 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' A' ' 23' ' ' VAL . 83.3 m-20 -87.79 -46.7 9.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.957 -1.089 . . . . 0.0 112.68 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.953 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.38 -50.05 81.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.774 -1.204 . . . . 0.0 111.092 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.6 Cg_endo -72.5 -49.8 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.193 0 C-N-CA 121.098 1.198 . . . . 0.0 109.713 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.08 -24.99 5.05 Favored Glycine 0 C--N 1.295 -1.726 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -76.73 -52.25 9.95 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.327 -1.102 . . . . 0.0 108.915 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 26' ' ' VAL . 34.9 m -55.15 -38.64 68.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.104 -1.038 . . . . 0.0 109.743 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -64.77 -32.7 74.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.064 -1.022 . . . . 0.0 109.383 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.44 -29.63 63.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.882 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 10.9 mmt -90.69 7.23 40.54 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.173 . . . . 0.0 111.52 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.0 OUTLIER 81.86 25.18 0.21 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.273 -0.892 . . . . 0.0 110.85 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.0 m-70 -96.15 174.32 6.96 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 4.2 mp0 -122.47 144.72 48.88 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.859 -1.151 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.037 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.5 tp -86.63 102.1 13.86 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.7 t -71.7 -50.81 36.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.74 -1.225 . . . . 0.0 110.343 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.926 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.44 130.84 16.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.173 -1.579 . . . . 0.0 110.626 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.037 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.78 162.95 12.83 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 118.919 -2.363 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.2 mm-40 -138.9 111.97 7.95 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.188 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.7 p -139.15 30.65 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.44 5.77 11.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.577 0.703 . . . . 0.0 110.045 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.94 126.69 2.72 Favored Glycine 0 C--N 1.293 -1.814 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.0 mt -35.86 147.04 0.18 Allowed Pre-proline 0 C--N 1.281 -2.39 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.854 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.7 Cg_endo -81.24 147.88 72.77 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.231 -1.987 . . . . 0.0 108.825 -0.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.889 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -71.4 161.52 30.93 Favored 'General case' 0 C--N 1.287 -2.143 0 O-C-N 121.553 -0.717 . . . . 0.0 109.879 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.892 ' HG3' HG23 ' A' ' 42' ' ' ILE . 2.4 mtt180 -145.55 153.06 40.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.683 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -152.83 122.61 6.9 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.145 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.2 tp -88.55 149.91 23.35 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.2 mt -142.81 109.97 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.788 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.894 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.4 ttp180 -71.48 110.0 5.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.19 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.644 ' HE3' HG22 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -54.91 132.76 47.35 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.8 -172.63 20.1 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' CA ' ' OE1' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.528 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 2' ' ' THR . 2.1 t -70.48 138.11 50.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.46 113.79 27.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 22.0 mt -81.81 -24.52 35.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.074 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.09 16.15 4.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.299 -0.876 . . . . 0.0 109.778 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 5' ' ' PHE . 6.9 t -46.19 174.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 104.32 0.41 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.023 -1.048 . . . . 0.0 109.464 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.4 Cg_endo -75.2 166.84 28.13 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.581 2.187 . . . . 0.0 110.391 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 8.7 m-20 -77.99 -23.6 48.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.123 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.586 ' CB ' HD12 ' A' ' 39' ' ' LEU . 13.1 m-70 -146.61 173.27 12.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 12' ' ' LEU . 46.8 m -145.62 161.77 39.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.446 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.974 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.6 tp -143.89 107.5 4.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 109.812 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 12' ' ' LEU . 46.7 t0 -73.45 134.53 43.96 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.91 16.65 2.66 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 123.731 1.729 . . . . 0.0 107.618 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.064 HD21 HG22 ' A' ' 42' ' ' ILE . 11.5 mt -77.39 107.65 9.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 95.51 -6.32 67.92 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 107.249 -2.341 . . . . 0.0 107.249 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.6 mt -90.9 147.89 22.83 Favored 'General case' 0 C--O 1.206 -1.194 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.89 148.05 36.33 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 117.664 -1.614 . . . . 0.0 109.653 179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.55 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.2 t -47.25 141.39 6.39 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.873 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.4 Cg_endo -88.69 3.6 69.89 Favored 'Cis proline' 0 C--N 1.307 -1.616 0 O-C-N 123.663 1.349 . . . . 0.0 111.628 -0.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 19.2 mm-40 -51.65 -47.35 90.12 Favored Pre-proline 0 N--CA 1.509 2.482 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.689 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.4 Cg_endo -69.53 -62.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.294 -2.33 0 C-N-CA 121.568 1.512 . . . . 0.0 108.215 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 52' ' ' ILE . 39.3 t -46.7 -26.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.21 -43.31 57.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.806 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.681 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.79 -41.29 97.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.234 -0.916 . . . . 0.0 109.13 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.893 HG23 HD23 ' A' ' 12' ' ' LEU . 72.7 t -63.92 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 108.717 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.635 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -66.33 -56.22 12.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 16.9 mtpt -57.88 -41.81 83.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.763 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.89 -34.26 77.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 26' ' ' VAL . 9.9 t -70.17 -27.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 49.8 mtp85 -76.62 -29.9 56.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 35.6 p30 -103.65 2.44 33.23 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.628 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 7.0 mtp -88.65 169.99 11.21 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -0.92 . . . . 0.0 109.97 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 8.6 mt-30 -129.21 154.22 80.52 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.3 Cg_endo -69.43 123.87 10.65 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 121.724 1.616 . . . . 0.0 109.624 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.11 26.26 8.98 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 4.6 mm-40 -121.19 -174.84 2.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.964 . . . . 0.0 109.714 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -139.83 150.3 44.51 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.091 -1.006 . . . . 0.0 110.823 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 29' ' ' THR . 4.1 tp -143.02 115.83 8.74 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -87.14 149.44 24.66 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.974 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -142.1 126.71 16.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.913 -1.117 . . . . 0.0 111.094 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.064 HG22 HD21 ' A' ' 15' ' ' LEU . 2.7 mt -101.49 158.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.7 126.75 3.02 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.134 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 6.4 p30 -103.42 -24.41 13.47 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -60.39 143.35 89.65 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -78.14 -19.5 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.522 2.148 . . . . 0.0 110.404 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.42 -2.53 58.65 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.642 -0.661 . . . . 0.0 110.098 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.786 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.0 p -87.5 -42.23 12.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.892 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.76 -33.27 64.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 108.71 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.72 -37.5 10.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.865 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 0.7 OUTLIER -86.21 -47.55 9.35 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.053 -1.029 . . . . 0.0 112.599 -177.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -52.0 -49.71 82.58 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.848 -1.158 . . . . 0.0 111.196 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.1 Cg_endo -72.3 -50.11 0.26 Allowed 'Trans proline' 0 C--N 1.296 -2.217 0 C-N-CA 121.134 1.223 . . . . 0.0 109.95 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.27 -24.91 5.4 Favored Glycine 0 C--N 1.295 -1.714 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.738 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -78.1 -53.32 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.269 -1.136 . . . . 0.0 108.731 178.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.772 ' SG ' HG11 ' A' ' 26' ' ' VAL . 31.2 m -53.1 -36.53 60.82 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.026 -1.046 . . . . 0.0 110.032 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.8 m -66.66 -33.97 76.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.71 -31.09 64.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 111.144 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.634 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 3.7 mmt -87.86 5.14 41.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.751 -1.218 . . . . 0.0 111.492 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 59' ' ' MET . 0.9 OUTLIER 83.42 27.11 0.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.346 -0.846 . . . . 0.0 111.132 178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.5 m-70 -96.54 174.15 6.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.104 -0.998 . . . . 0.0 108.452 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -122.59 144.63 48.98 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.78 -1.2 . . . . 0.0 110.97 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.032 HD21 ' CG ' ' A' ' 66' ' ' LYS . 5.3 tp -87.95 102.1 14.39 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.083 ' CG1' HD23 ' A' ' 76' ' ' LEU . 72.0 t -72.87 -50.02 35.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.552 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.074 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.96 130.37 16.7 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.133 -1.605 . . . . 0.0 110.72 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.032 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.9 160.66 14.14 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 118.812 -2.43 . . . . 0.0 110.812 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -138.64 111.67 7.88 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.479 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.9 p -137.61 31.33 2.55 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.77 5.21 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 110.064 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 132.87 126.94 2.75 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.8 mt -36.4 146.79 0.21 Allowed Pre-proline 0 C--N 1.281 -2.407 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.568 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' CD2' ' A' ' 15' ' ' LEU . 43.9 Cg_endo -81.57 148.24 71.58 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.177 -2.01 . . . . 0.0 108.95 -0.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.892 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.5 m-85 -72.07 164.6 25.87 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 121.467 -0.771 . . . . 0.0 110.196 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 7.4 mtm180 -147.6 151.27 35.95 Favored 'General case' 0 C--O 1.201 -1.491 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.728 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.03 123.3 7.09 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.993 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD23 ' CG1' ' A' ' 64' ' ' VAL . 19.9 tp -89.0 150.9 22.58 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.4 mt -145.93 107.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.625 -1.23 . . . . 0.0 109.585 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.9 ptm180 -73.53 122.92 22.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.055 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -64.8 105.9 1.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.43 169.45 30.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.806 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' THR . 1.1 t -53.0 109.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -114.41 97.12 6.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.86 . . . . 0.0 109.813 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 75.5 mt -87.56 -10.77 50.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.182 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.966 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.6 m-30 -85.96 17.05 3.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 5' ' ' PHE . 45.6 m -44.03 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 109.648 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 6' ' ' SER . 1.7 p -46.24 103.27 0.34 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 109.337 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.6 Cg_endo -75.85 174.16 13.28 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.722 2.281 . . . . 0.0 110.237 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.8 m-20 -85.2 -22.23 28.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.606 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.0 m-70 -145.95 174.05 11.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 12' ' ' LEU . 31.6 m -145.35 159.3 43.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.085 -1.01 . . . . 0.0 109.813 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.882 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.2 tp -148.28 112.63 5.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.407 -0.808 . . . . 0.0 109.698 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' N ' HD12 ' A' ' 12' ' ' LEU . 1.4 t70 -82.21 140.95 33.4 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.28 20.89 1.73 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 123.949 1.833 . . . . 0.0 108.218 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.773 HD21 ' HB ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -80.54 111.27 16.8 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 92.76 -2.09 72.4 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 107.126 -2.39 . . . . 0.0 107.126 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 4.1 mt -95.28 148.52 22.33 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.05 148.39 36.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.536 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.1 t -47.06 141.62 5.79 Favored Pre-proline 0 C--N 1.287 -2.11 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.591 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.1 Cg_endo -88.58 3.75 69.83 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 O-C-N 123.658 1.346 . . . . 0.0 111.805 -0.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 4.5 mt-10 -53.57 -47.2 97.25 Favored Pre-proline 0 N--CA 1.511 2.58 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.705 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.6 Cg_endo -69.82 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.41 0 C-N-CA 121.827 1.685 . . . . 0.0 108.069 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.893 HG22 ' HA ' ' A' ' 52' ' ' ILE . 76.5 t -48.26 -25.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -72.55 -42.3 64.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.441 -0.787 . . . . 0.0 109.858 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.696 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.08 -46.23 91.48 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.187 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.882 HG23 ' CD2' ' A' ' 12' ' ' LEU . 74.8 t -60.49 -27.63 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 108.993 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.661 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.95 -54.69 26.6 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.963 -1.086 . . . . 0.0 109.194 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -59.36 -47.9 83.67 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.896 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -61.27 -36.72 80.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.9 t -68.18 -28.67 41.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 14.0 mtp85 -78.03 -28.25 49.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 38.7 p30 -105.55 4.16 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.43 -0.794 . . . . 0.0 109.511 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.531 ' HE3' ' HB3' ' A' ' 37' ' ' GLU . 5.8 mtp -89.54 170.56 10.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.573 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.9 mt-30 -125.68 153.38 73.0 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 30.2 Cg_endo -70.4 124.0 10.41 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.666 1.578 . . . . 0.0 109.746 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.91 21.93 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 5.9 mp0 -115.24 -175.57 2.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.494 -1.003 . . . . 0.0 109.311 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -139.12 155.42 47.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 110.662 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.896 HD13 HG21 ' A' ' 29' ' ' THR . 3.6 tp -141.07 118.39 11.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CB ' ' HG3' ' A' ' 8' ' ' PRO . 18.6 tp -87.98 141.23 28.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.0 107.798 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.815 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -136.74 154.54 32.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.104 -0.998 . . . . 0.0 110.608 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.933 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -129.35 163.62 34.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.882 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -164.34 129.42 2.78 Favored 'General case' 0 C--N 1.276 -2.599 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.202 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.569 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -103.7 -27.58 12.19 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 176.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -60.42 141.93 91.07 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.7 Cg_endo -77.36 -18.71 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.449 2.099 . . . . 0.0 110.09 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.08 -2.88 58.75 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.803 -0.561 . . . . 0.0 110.19 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.882 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.2 p -88.04 -40.19 14.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.97 -1.081 . . . . 0.0 109.439 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.867 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -57.56 -30.82 65.54 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -96.81 -38.07 10.01 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.96 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' HG21 ' A' ' 23' ' ' VAL . 41.2 m-20 -87.16 -46.5 9.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 112.54 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.893 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.2 mt -52.65 -50.67 79.4 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.735 -1.228 . . . . 0.0 110.932 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 27.5 Cg_endo -72.04 -49.8 0.29 Allowed 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 121.143 1.228 . . . . 0.0 109.918 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.14 -25.12 5.28 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.72 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -76.95 -54.33 6.71 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.293 -1.122 . . . . 0.0 108.828 178.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.778 ' SG ' HG11 ' A' ' 26' ' ' VAL . 32.9 m -52.98 -37.56 61.44 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.872 -1.142 . . . . 0.0 109.736 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.8 m -67.2 -33.06 74.58 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.486 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.35 -32.21 71.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.519 -0.738 . . . . 0.0 111.074 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.624 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -88.88 2.97 52.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.612 -1.305 . . . . 0.0 111.39 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 59' ' ' MET . 0.5 OUTLIER 85.33 25.15 0.08 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.6 -0.688 . . . . 0.0 110.694 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.624 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 2.7 m-70 -96.05 175.04 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 2.6 mm-40 -122.4 143.61 49.55 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.611 -1.305 . . . . 0.0 111.614 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.049 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.0 tp -86.01 102.87 14.19 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.076 ' CG1' HD23 ' A' ' 76' ' ' LEU . 69.4 t -72.23 -49.07 45.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.859 -1.15 . . . . 0.0 110.77 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.966 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.36 130.24 16.2 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.172 -1.58 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.049 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.65 162.32 13.19 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 118.978 -2.326 . . . . 0.0 110.993 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -139.41 112.13 7.85 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.585 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -137.31 31.1 2.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 5.2 m-20 -79.05 5.35 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.629 0.728 . . . . 0.0 110.214 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.0 126.16 2.68 Favored Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 8.9 mt -35.64 147.25 0.17 Allowed Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.874 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.9 Cg_endo -81.26 147.43 71.89 Favored 'Cis proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.178 -2.009 . . . . 0.0 108.936 -0.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.867 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.5 m-85 -69.97 161.62 29.67 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.563 -0.711 . . . . 0.0 110.032 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.932 ' HG3' HG23 ' A' ' 42' ' ' ILE . 10.7 mtp180 -146.06 152.68 39.72 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.686 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.1 m-85 -152.31 123.92 7.84 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.14 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.076 HD23 ' CG1' ' A' ' 64' ' ' VAL . 16.6 tp -88.3 150.74 23.07 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.677 HG21 ' SG ' ' A' ' 56' ' ' CYS . 4.0 mt -143.85 109.62 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.273 -1.371 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.877 ' H ' HG23 ' A' ' 64' ' ' VAL . 4.4 ttt180 -72.09 112.2 7.97 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.664 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -62.95 119.35 9.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.01 -172.08 12.52 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' CG ' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 2' ' ' THR . 15.1 t -74.32 113.65 11.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.25 143.11 31.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 59.6 mt -64.82 -37.04 86.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.535 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.08 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.2 m-30 -86.44 16.08 4.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' PHE . 67.5 m -46.51 174.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 108.974 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -47.13 104.25 0.4 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.923 -1.111 . . . . 0.0 109.045 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.32 166.97 27.73 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.61 2.206 . . . . 0.0 110.303 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 5.4 m-20 -77.88 -22.59 49.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 109.296 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.676 ' CB ' HD12 ' A' ' 39' ' ' LEU . 17.5 m-70 -147.97 176.18 10.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 109.489 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 12' ' ' LEU . 43.6 m -145.39 161.19 40.24 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.153 -0.967 . . . . 0.0 109.57 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 41' ' ' ILE . 3.3 tp -146.11 112.22 5.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.642 ' N ' HD12 ' A' ' 12' ' ' LEU . 28.3 t70 -80.21 141.27 35.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.79 20.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.877 1.798 . . . . 0.0 108.134 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.02 HD21 HG22 ' A' ' 42' ' ' ILE . 1.2 mt -81.41 106.95 13.78 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 98.85 -4.64 59.37 Favored Glycine 0 C--N 1.284 -2.359 0 N-CA-C 106.886 -2.486 . . . . 0.0 106.886 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.9 mt -94.52 148.04 22.65 Favored 'General case' 0 C--O 1.208 -1.122 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.08 147.72 35.49 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 117.694 -1.603 . . . . 0.0 109.444 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.24 141.6 6.22 Favored Pre-proline 0 C--N 1.287 -2.111 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.762 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.9 Cg_endo -88.79 3.49 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 O-C-N 123.64 1.337 . . . . 0.0 111.695 -0.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 mt-10 -52.12 -47.13 92.84 Favored Pre-proline 0 N--CA 1.511 2.594 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.698 ' CG ' HG22 ' A' ' 48' ' ' THR . 27.4 Cg_endo -70.15 -61.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.293 -2.366 0 N-CA-C 107.945 -1.598 . . . . 0.0 107.945 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 25.7 t -46.5 -26.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.36 -42.42 59.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.79 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.687 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -60.76 -43.08 98.46 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.145 -0.972 . . . . 0.0 109.058 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 30' ' ' VAL . 63.0 t -62.59 -30.38 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 108.995 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -68.18 -57.21 6.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.861 . . . . 0.0 109.529 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -56.93 -35.27 68.85 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.808 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -70.71 -34.2 71.69 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.1 t -70.5 -25.75 27.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 44.2 mtp85 -79.73 -31.8 41.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -101.38 2.24 39.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.393 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.576 ' CB ' ' HD3' ' A' ' 79' ' ' LYS . 4.2 mtp -88.87 -177.75 5.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.524 ' N ' ' HE2' ' A' ' 79' ' ' LYS . 2.3 mt-30 -136.0 154.42 77.59 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 29.7 Cg_endo -69.76 128.34 15.89 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.712 1.608 . . . . 0.0 109.253 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 23.75 21.24 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' CB ' ' CE ' ' A' ' 33' ' ' MET . 6.1 mt-10 -117.53 -175.53 2.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.465 -1.021 . . . . 0.0 109.72 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -142.02 140.94 32.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 110.786 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 29' ' ' THR . 4.3 tp -129.62 118.48 22.04 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.548 HD12 ' H ' ' A' ' 41' ' ' ILE . 21.6 tp -87.33 149.25 24.64 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.897 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.7 mt -141.86 153.13 18.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.986 -1.071 . . . . 0.0 110.962 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.02 HG22 HD21 ' A' ' 15' ' ' LEU . 1.3 mt -127.13 159.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.61 128.18 2.88 Favored 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.175 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.1 p30 -104.91 -24.13 12.9 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -61.32 142.26 93.74 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.4 Cg_endo -77.29 -18.63 13.98 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.369 2.046 . . . . 0.0 110.325 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 51' ' ' ASP . . . -90.93 -2.7 57.7 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.686 -0.633 . . . . 0.0 110.163 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.826 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 2.1 p -86.19 -40.95 15.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 109.472 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -55.73 -32.88 63.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 108.758 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -96.52 -38.07 10.14 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.094 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 47' ' ' ALA . 48.6 m-20 -84.5 -47.3 10.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.034 -1.041 . . . . 0.0 112.584 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.3 mt -51.48 -49.45 82.33 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.708 -1.245 . . . . 0.0 111.25 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 25.8 Cg_endo -72.31 -50.32 0.25 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 121.04 1.16 . . . . 0.0 109.967 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.87 -25.21 4.86 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.766 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -77.13 -53.02 8.29 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.306 -1.114 . . . . 0.0 108.778 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.857 ' SG ' HG11 ' A' ' 26' ' ' VAL . 53.1 m -53.88 -37.64 63.94 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.011 -1.055 . . . . 0.0 109.971 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.5 m -63.28 -34.4 77.6 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.129 -0.982 . . . . 0.0 109.595 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.89 -38.49 76.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.619 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 4.8 mmt -77.33 4.58 10.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.896 -1.127 . . . . 0.0 110.941 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 59' ' ' MET . 5.0 tp10 81.0 22.33 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.1 m-70 -95.76 174.4 6.98 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 108.952 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.7 mt-10 -122.74 147.75 46.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.064 -1.022 . . . . 0.0 111.589 -178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.093 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.6 tp -87.61 100.42 12.79 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.085 ' CG1' HD23 ' A' ' 76' ' ' LEU . 74.2 t -69.41 -49.82 56.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 110.514 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.08 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -146.39 130.77 17.63 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.219 -1.551 . . . . 0.0 110.805 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.093 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.32 161.52 13.57 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 118.885 -2.384 . . . . 0.0 110.624 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -138.09 111.67 8.16 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.569 179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -136.76 31.88 2.75 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -78.15 4.85 11.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.511 -0.743 . . . . 0.0 110.041 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 131.41 126.89 2.81 Favored Glycine 0 C--N 1.293 -1.843 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.815 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.6 mt -35.21 146.1 0.18 Allowed Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.672 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 42' ' ' ILE . 43.5 Cg_endo -81.72 148.27 70.83 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.19 -2.004 . . . . 0.0 109.058 -1.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.14 165.61 23.21 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 121.555 -0.716 . . . . 0.0 110.329 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.634 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 12.8 mtm180 -147.78 152.12 37.18 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.719 ' OH ' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -153.31 123.73 7.13 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.17 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.085 HD23 ' CG1' ' A' ' 64' ' ' VAL . 15.8 tp -89.31 149.86 22.85 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 56' ' ' CYS . 4.3 mt -145.15 107.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.077 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.9 ' H ' HG23 ' A' ' 64' ' ' VAL . 8.5 ptm180 -74.06 118.32 16.88 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.106 -1.438 . . . . 0.0 109.01 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.576 ' HD3' ' CB ' ' A' ' 33' ' ' MET . 7.8 ttpt -67.69 107.64 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 166.78 167.9 28.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 117.969 -1.461 . . . . 0.0 109.54 179.87 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 p -89.23 121.79 31.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.5 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.04 145.49 41.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.548 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' ' 65' ' ' ALA . 4.8 mt -73.63 -6.06 44.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.079 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.1 m-30 -86.48 16.62 4.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' PHE . 64.5 m -45.64 174.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.963 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 6' ' ' SER . 99.7 p -46.74 104.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.908 -1.12 . . . . 0.0 109.244 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 33.5 Cg_endo -74.77 165.04 32.35 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.554 2.169 . . . . 0.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 32.8 m-20 -78.93 -23.11 44.89 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.291 -0.881 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.631 ' CB ' HD12 ' A' ' 39' ' ' LEU . 16.8 m-70 -147.2 175.25 10.88 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 12' ' ' LEU . 50.1 m -145.61 161.99 38.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.99 ' HB3' HG23 ' A' ' 41' ' ' ILE . 2.2 tp -146.62 107.99 4.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.927 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' N ' HD12 ' A' ' 12' ' ' LEU . 24.8 t0 -74.17 133.46 42.76 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -138.23 17.65 2.78 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 123.826 1.774 . . . . 0.0 107.362 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.083 HD21 HG22 ' A' ' 42' ' ' ILE . 13.0 mt -79.08 106.44 11.12 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.55 -4.95 62.13 Favored Glycine 0 C--N 1.282 -2.464 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.7 mt -92.72 147.79 22.58 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.1 ptt180 -142.87 147.77 35.91 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.385 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.6 t -47.15 141.53 6.05 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.798 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.79 3.43 69.94 Favored 'Cis proline' 0 C--N 1.307 -1.646 0 O-C-N 123.744 1.392 . . . . 0.0 111.603 -0.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.652 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 mt-10 -52.03 -47.29 91.97 Favored Pre-proline 0 N--CA 1.51 2.567 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' CG ' HG22 ' A' ' 48' ' ' THR . 25.7 Cg_endo -69.53 -61.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.843 1.695 . . . . 0.0 108.179 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 52' ' ' ILE . 60.0 t -47.32 -26.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -75.41 -41.34 56.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.427 -0.795 . . . . 0.0 109.605 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.643 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.7 mtt -61.48 -43.53 98.7 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.293 -0.88 . . . . 0.0 108.928 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 HD23 ' A' ' 12' ' ' LEU . 52.9 t -61.45 -29.8 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.082 -1.011 . . . . 0.0 108.586 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.644 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -64.21 -57.58 9.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.275 -0.891 . . . . 0.0 109.091 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 1.6 mttp -56.63 -42.16 78.39 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.756 0.789 . . . . 0.0 108.928 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.756 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.91 -33.87 76.68 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 26' ' ' VAL . 13.8 t -72.27 -25.81 23.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 9.6 mtp85 -74.46 -32.21 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -106.3 2.88 27.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.269 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.57 ' CE ' ' HB2' ' A' ' 79' ' ' LYS . 6.5 mtp -89.6 165.27 14.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.9 mm-40 -126.22 153.31 74.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 29.7 Cg_endo -70.42 122.48 8.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.806 1.671 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.68 20.87 8.21 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 106.906 -2.477 . . . . 0.0 106.906 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 8.4 mp0 -122.01 -175.25 3.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.62 -0.929 . . . . 0.0 109.593 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -138.0 156.36 47.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 110.172 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD23 HD11 ' A' ' 41' ' ' ILE . 4.3 tp -145.57 117.77 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . 24.8 tp -86.45 144.59 27.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.99 HG23 ' HB3' ' A' ' 12' ' ' LEU . 1.9 mt -140.08 123.83 18.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.964 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.083 HG22 HD21 ' A' ' 15' ' ' LEU . 1.8 mt -99.13 160.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.813 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -163.11 126.63 2.82 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.935 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 9.1 p30 -101.94 -24.41 14.01 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.656 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.57 141.63 94.65 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 33.9 Cg_endo -78.14 -19.12 12.34 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.439 2.092 . . . . 0.0 110.453 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.22 -3.03 58.93 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.057 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.813 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 5.7 p -88.29 -41.35 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.06 -1.025 . . . . 0.0 109.123 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.883 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.59 -34.84 62.62 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -96.56 -37.77 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.082 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' A' ' 23' ' ' VAL . 9.2 m-20 -85.86 -46.36 10.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.961 -1.087 . . . . 0.0 112.677 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.807 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.1 mt -52.37 -49.25 86.37 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.741 -1.224 . . . . 0.0 111.146 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.8 Cg_endo -72.43 -50.79 0.22 Allowed 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 121.14 1.227 . . . . 0.0 109.992 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -49.26 -24.91 5.38 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.806 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -77.06 -51.75 10.51 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.319 -1.106 . . . . 0.0 108.736 178.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG21 ' A' ' 77' ' ' ILE . 28.7 m -53.22 -38.98 63.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.822 -1.174 . . . . 0.0 109.407 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.4 m -61.43 -34.74 75.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.43 -41.01 89.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 0.0 110.681 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.633 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -80.3 4.93 16.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.96 -1.087 . . . . 0.0 111.707 -178.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 59' ' ' MET . 1.2 mm-40 81.87 23.71 0.24 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.199 -0.938 . . . . 0.0 110.6 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.3 m-70 -95.51 173.65 7.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.551 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 8.0 mt-10 -123.51 143.94 49.86 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 111.719 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 66' ' ' LYS . 2.9 tp -83.95 102.05 12.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.092 ' CG1' HD23 ' A' ' 76' ' ' LEU . 77.6 t -70.63 -47.73 62.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 110.7 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.079 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -148.38 130.68 15.59 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.232 -1.542 . . . . 0.0 110.782 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.102 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -99.15 161.32 13.69 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 118.837 -2.414 . . . . 0.0 110.675 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 15.7 mm-40 -139.03 111.64 7.66 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.386 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.5 p -137.0 32.86 2.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.15 4.7 11.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.506 -0.746 . . . . 0.0 110.021 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 133.05 125.77 2.65 Favored Glycine 0 C--N 1.292 -1.878 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.873 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 9.1 mt -35.95 147.29 0.18 Allowed Pre-proline 0 C--N 1.28 -2.416 0 CA-C-N 115.123 -0.539 . . . . 0.0 110.719 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.1 Cg_endo -81.12 148.71 74.75 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.156 -2.018 . . . . 0.0 109.007 -0.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.883 ' CD2' HG22 ' A' ' 49' ' ' THR . 7.0 m-85 -71.57 165.77 23.22 Favored 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.486 -0.759 . . . . 0.0 110.399 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.628 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 27.7 mtm180 -147.74 151.42 36.05 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.725 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -152.98 124.98 7.94 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.887 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.092 HD23 ' CG1' ' A' ' 64' ' ' VAL . 22.7 tp -88.52 152.38 21.9 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.806 HG21 ' SG ' ' A' ' 56' ' ' CYS . 3.5 mt -143.96 108.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 118.212 -1.395 . . . . 0.0 110.214 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.897 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.65 108.59 5.08 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.984 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' CE ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -59.15 137.47 57.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.33 -0.856 . . . . 0.0 108.783 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . -160.13 -172.54 27.49 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.6 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.5 p -111.0 109.31 19.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.23 130.99 34.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.587 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . 95.8 mt -72.11 -32.08 66.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.091 ' CE1' ' HB3' ' A' ' 65' ' ' ALA . 3.4 m-30 -87.26 16.26 5.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 109.782 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 5' ' ' PHE . 73.1 m -46.49 174.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 108.967 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.89 104.22 0.4 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.92 -1.113 . . . . 0.0 109.322 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 35.2 Cg_endo -75.22 168.06 25.51 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.581 2.188 . . . . 0.0 110.443 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 3.5 m-20 -82.22 -24.07 35.07 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.585 ' CB ' HD12 ' A' ' 39' ' ' LEU . 15.0 m-70 -144.16 172.45 12.89 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 35.9 m -145.34 160.62 41.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.867 ' CD2' HG23 ' A' ' 26' ' ' VAL . 4.3 tp -145.27 110.42 5.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.598 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 t70 -77.28 139.97 39.94 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 42' ' ' ILE . . . -144.54 19.09 1.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 123.874 1.797 . . . . 0.0 107.929 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.043 HD21 ' CG2' ' A' ' 42' ' ' ILE . 14.5 mt -79.3 107.31 11.97 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 97.38 -5.18 62.6 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 107.254 -2.339 . . . . 0.0 107.254 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 3.8 mt -93.04 148.01 22.36 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -142.78 148.8 37.78 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 117.654 -1.618 . . . . 0.0 109.257 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 8.9 t -47.08 141.46 5.94 Favored Pre-proline 0 C--N 1.286 -2.159 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.746 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 24' ' ' MET . 44.2 Cg_endo -88.73 3.64 69.91 Favored 'Cis proline' 0 C--N 1.307 -1.628 0 O-C-N 123.664 1.349 . . . . 0.0 111.69 -0.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 2.1 mt-10 -52.8 -47.03 96.29 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CG ' HG22 ' A' ' 48' ' ' THR . 26.0 Cg_endo -69.62 -62.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 121.853 1.702 . . . . 0.0 108.198 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG22 ' HA ' ' A' ' 52' ' ' ILE . 42.9 t -47.46 -26.3 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' PRO . 5.6 mmt -75.45 -41.12 56.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.49 -0.756 . . . . 0.0 109.721 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.39 -43.19 99.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.181 -0.949 . . . . 0.0 109.032 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG23 ' CD2' ' A' ' 12' ' ' LEU . 87.7 t -64.56 -26.79 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 108.214 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HG2' ' CZ ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -64.81 -59.62 4.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.486 -0.759 . . . . 0.0 109.087 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.6 mtmm -58.75 -42.2 88.28 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.759 HG21 HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -63.1 -36.37 83.35 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 26' ' ' VAL . 5.3 t -68.54 -27.9 38.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -76.71 -30.27 56.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 29' ' ' THR . 6.0 p-10 -103.16 9.42 38.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 29' ' ' THR . 7.1 mtp -101.96 -178.41 3.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -135.52 152.25 76.05 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.21 116.82 4.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.883 1.722 . . . . 0.0 109.958 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 25.89 4.77 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 7.2 mp0 -123.81 -174.48 2.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.807 -0.82 . . . . 0.0 109.355 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -134.84 150.78 50.53 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.125 -0.985 . . . . 0.0 110.535 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD13 HG21 ' A' ' 29' ' ' THR . 3.9 tp -141.42 116.48 9.93 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' CD1' ' CD2' ' A' ' 5' ' ' PHE . 6.2 tp -88.38 143.32 27.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.827 HG23 ' HB3' ' A' ' 12' ' ' LEU . 2.3 mt -134.2 149.75 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.753 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.043 ' CG2' HD21 ' A' ' 15' ' ' LEU . 1.7 mt -123.06 153.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB1' ' OG1' ' A' ' 48' ' ' THR . . . -162.36 127.77 3.38 Favored 'General case' 0 C--N 1.279 -2.464 0 C-N-CA 118.643 -1.223 . . . . 0.0 109.454 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 16' ' ' GLY . 7.5 p30 -102.84 -24.07 13.72 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.63 ' OD2' HG23 ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.13 141.65 93.71 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 45' ' ' ASP . 34.7 Cg_endo -77.96 -19.34 12.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.464 2.11 . . . . 0.0 110.39 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -88.07 -3.01 58.94 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.634 -0.666 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.776 ' OG1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 p -87.38 -41.67 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.876 HG22 ' CD2' ' A' ' 73' ' ' TYR . 1.1 p -54.6 -34.51 62.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 108.691 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -96.76 -37.99 10.07 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.01 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 51' ' ' ASP . 1.9 m-20 -84.11 -48.4 9.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.989 -1.07 . . . . 0.0 112.529 -177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 23' ' ' VAL . 1.7 mt -50.53 -47.83 83.29 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.847 -1.158 . . . . 0.0 111.359 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 52' ' ' ILE . 26.3 Cg_endo -72.95 -50.51 0.2 Allowed 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 121.073 1.182 . . . . 0.0 109.973 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' PRO . . . -48.11 -25.86 4.24 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.801 ' CB ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -76.83 -52.85 8.75 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.267 -1.137 . . . . 0.0 108.761 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.725 ' SG ' HG11 ' A' ' 26' ' ' VAL . 43.2 m -51.97 -37.61 53.65 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.02 -1.05 . . . . 0.0 109.608 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 m -61.41 -39.15 89.67 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.371 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -65.58 -34.71 78.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.325 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.628 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 9.5 mmt -81.28 2.98 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 111.113 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 59' ' ' MET . 3.6 tt0 79.4 23.5 0.51 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 59' ' ' MET . 3.6 m-70 -95.24 174.18 7.18 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 109.056 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 1.1 mm-40 -122.53 144.48 49.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 111.15 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.086 HD21 ' CG ' ' A' ' 66' ' ' LYS . 3.5 tp -83.98 102.59 12.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.097 ' CG1' HD23 ' A' ' 76' ' ' LEU . 70.6 t -71.28 -49.41 48.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.787 -1.195 . . . . 0.0 110.427 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.091 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . . . -147.37 130.94 16.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.241 -1.537 . . . . 0.0 110.774 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.086 ' CG ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -98.99 161.26 13.72 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 118.877 -2.389 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.3 111.56 8.5 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.6 p -137.13 32.75 2.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.47 4.62 10.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.629 0.728 . . . . 0.0 109.98 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' LEU . . . 129.78 126.17 2.8 Favored Glycine 0 C--N 1.293 -1.828 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.822 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 7.9 mt -33.73 145.92 0.13 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 115.058 -0.571 . . . . 0.0 110.807 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.4 Cg_endo -81.7 149.11 72.67 Favored 'Cis proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.267 -1.972 . . . . 0.0 109.119 -0.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.876 ' CD2' HG22 ' A' ' 49' ' ' THR . 6.3 m-85 -72.51 166.19 23.15 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.564 -0.71 . . . . 0.0 110.738 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.645 ' O ' ' CD1' ' A' ' 75' ' ' TYR . 2.0 mtt180 -147.95 152.14 37.01 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.753 ' OH ' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -153.81 123.18 6.58 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.196 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.097 HD23 ' CG1' ' A' ' 64' ' ' VAL . 24.9 tp -88.99 151.64 22.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.639 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 4.2 mt -144.17 108.47 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.94 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.915 ' H ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -72.05 106.75 4.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.289 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.797 ' HD2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -50.81 151.47 2.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.04 -172.45 35.8 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 60' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.937 . . . . . . . . 1 1 . 1 stop_ save_